Classification and properties of tendons according to their functions.
\\n\\n
\\n"}]',published:!0,mainMedia:{caption:"Milestone",originalUrl:"/media/original/124"}},components:[{type:"htmlEditorComponent",content:'
Barely three months into the new year and we are happy to announce a monumental milestone reached - 150 million downloads.
\n\nThis achievement solidifies IntechOpen’s place as a pioneer in Open Access publishing and the home to some of the most relevant scientific research available through Open Access.
\n\nWe are so proud to have worked with so many bright minds throughout the years who have helped us spread knowledge through the power of Open Access and we look forward to continuing to support some of the greatest thinkers of our day.
\n\nThank you for making IntechOpen your place of learning, sharing, and discovery, and here’s to 150 million more!
\n\n\n\n\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"10907",leadTitle:null,fullTitle:"Herbs and Spices - New Processing Technologies",title:"Herbs and Spices",subtitle:"New Processing Technologies",reviewType:"peer-reviewed",abstract:"Herbs and Spices - New Processing Technologies is a collection of research and review chapters offering a comprehensive overview of recent developments in the field of herbs and spices, with a focus on plants containing bioactive components and the utilization of novel processing technologies in the development of functional products. The book consists of four sections containing fourteen chapters written by various researchers and edited by an expert active in the research of plants and bioactive compounds.",isbn:"978-1-83969-609-1",printIsbn:"978-1-83969-608-4",pdfIsbn:"978-1-83969-610-7",doi:"10.5772/intechopen.95216",price:119,priceEur:129,priceUsd:155,slug:"herbs-and-spices-new-processing-technologies",numberOfPages:276,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"f95ecdf9c56db9567aa29b880dba5836",bookSignature:"Rabia Shabir Ahmad",publishedDate:"December 1st 2021",coverURL:"https://cdn.intechopen.com/books/images_new/10907.jpg",numberOfDownloads:2550,numberOfWosCitations:0,numberOfCrossrefCitations:1,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:4,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:5,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"March 1st 2021",dateEndSecondStepPublish:"March 29th 2021",dateEndThirdStepPublish:"May 28th 2021",dateEndFourthStepPublish:"August 16th 2021",dateEndFifthStepPublish:"October 15th 2021",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"239057",title:"Dr.",name:"Rabia Shabir",middleName:null,surname:"Ahmad",slug:"rabia-shabir-ahmad",fullName:"Rabia Shabir Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/239057/images/system/239057.jpg",biography:"Dr. Rabia Shabir Ahmad has a strong background in academics, teaching, and research. She successfully completed doctoral research funded by the Indigenous Fellowship Program, Higher Education Commission (HEC), Pakistan. During her academic career, Dr. Ahmad was awarded and successfully completed a Start-Up Research Grant Program (SRGP) and National Research Program for Universities (NRPU) project from the HEC as Principal Investigator in the area of functional foods. Along with her teaching and research supervising responsibilities, Dr. Ahmad is also a journal reviewer. She has published numerous research papers in international and national journals and edited several books.",institutionString:"Government College University, Faisalabad",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"991",title:"Herbalism",slug:"herbalism"}],chapters:[{id:"79151",title:"Introductory Chapter: Herbs and Spices - An Overview",doi:"10.5772/intechopen.100725",slug:"introductory-chapter-herbs-and-spices-an-overview",totalDownloads:114,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Rabia Shabir Ahmad, Muhammad Imran, Muhammad Kamran Khan, Muhammad Haseeb Ahmad, Muhammad Sajid Arshad, Huda Ateeq and Muhammad Abdul Rahim",downloadPdfUrl:"/chapter/pdf-download/79151",previewPdfUrl:"/chapter/pdf-preview/79151",authors:[{id:"239057",title:"Dr.",name:"Rabia Shabir",surname:"Ahmad",slug:"rabia-shabir-ahmad",fullName:"Rabia Shabir Ahmad"},{id:"208645",title:"Dr.",name:"Muhammad",surname:"Kamran Khan",slug:"muhammad-kamran-khan",fullName:"Muhammad Kamran Khan"},{id:"208646",title:"Dr.",name:"Muhammad",surname:"Imran",slug:"muhammad-imran",fullName:"Muhammad Imran"},{id:"292145",title:"Dr.",name:"Muhammad",surname:"Haseeb Ahmad",slug:"muhammad-haseeb-ahmad",fullName:"Muhammad Haseeb Ahmad"},{id:"440128",title:"Dr.",name:"Muhammad Sajid",surname:"Arshad",slug:"muhammad-sajid-arshad",fullName:"Muhammad Sajid Arshad"},{id:"440129",title:"Ph.D.",name:"Huda",surname:"Ateeq",slug:"huda-ateeq",fullName:"Huda Ateeq"},{id:"440130",title:"Dr.",name:"Muhammad Abdul",surname:"Rahim",slug:"muhammad-abdul-rahim",fullName:"Muhammad Abdul Rahim"}],corrections:null},{id:"77429",title:"Medicinal Herbs: Important Source of Bioactive Compounds for Food Industry",doi:"10.5772/intechopen.98819",slug:"medicinal-herbs-important-source-of-bioactive-compounds-for-food-industry",totalDownloads:169,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Medicinal herbs accompany people throughout life – from birth to the grave. Almost every day they come to our table as a part of food in various forms, many are used for technical and bioenergetics purposes, and there is also a large group of plants used in medicine, pharmacy and food industry. In the last decade, the consumption of herbs and spices has increased. They grow spontaneously and free of chemical additives, and some studies have shown higher nutritional value, often more significant compared to other common food plants. Medicinal herbs become increasingly important due to its potential beneficial health effects related to its nutritional composition, such as the presence of vitamins, phenolic, anthocyanins, flavonoids, tannins, among others. These raw materials are considered to be promising, economically and ecologically advantageous for the food industry. In this chapter will be describe selected medicinal herbs from Lamiaceae family – bioactive compounds and possibility for using in food industry.",signatures:"Eva Ivanišová, Miroslava Kačániová, Tatsiana A. Savitskaya and Dmitry D. Grinshpan",downloadPdfUrl:"/chapter/pdf-download/77429",previewPdfUrl:"/chapter/pdf-preview/77429",authors:[{id:"352448",title:"Ph.D.",name:"Eva",surname:"Ivanišová",slug:"eva-ivanisova",fullName:"Eva Ivanišová"}],corrections:null},{id:"78517",title:"Structure: Activity and Emerging Applications of Spices and Herbs",doi:"10.5772/intechopen.99661",slug:"structure-activity-and-emerging-applications-of-spices-and-herbs",totalDownloads:138,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Herbs and spices are plant parts (herbs from leaves and spices from other parts) that are conventionally used in their fresh or dried state for flavouring, natural condiments, preservatives and for medicinal purposes. Worldwide, most spices are classified on the basis of taste, season of growth, economic importance, growth habit and plant part used. Black pepper, chilies, small cardamom, ginger and turmeric are some of the widely used spices while common herbs include thyme, basil and bay leaves. These herbs are basically classified according to usage, active constituents and period of life. Secondary metabolites such as Eugenol, thymol, limonene, cuminaldehyde, curcumin, piperine, quercetin, luteolin in these plant parts have been found to be responsible for anticancer, antimicrobial, antiviral, antidiabetic, antioxidant, anti-inflammatory and hypocholesterolemic effects. Their application in water fortification, milk and cheese processing, production of beauty products and pesticides among others could not be underestimated. Finally, adulteration, toxicity and allergic reactions are some of the identified limitations and challenges often encountered in the use of herbs and spices.",signatures:"Adeyemi Ojutalayo Adeeyo, Tshianeo Mellda Ndou, Mercy Adewumi Alabi, Hosana Dumisani Mkoyi, Erinfolami Motunrayo Enitan, Daniso Beswa, Rachel Makungo and John O. Odiyo",downloadPdfUrl:"/chapter/pdf-download/78517",previewPdfUrl:"/chapter/pdf-preview/78517",authors:[{id:"210242",title:"Ms.",name:"Rachel",surname:"Makungo",slug:"rachel-makungo",fullName:"Rachel Makungo"},{id:"261205",title:"Dr.",name:"Erinfolami Motunrayo",surname:"Enitan",slug:"erinfolami-motunrayo-enitan",fullName:"Erinfolami Motunrayo Enitan"},{id:"261217",title:"Mr.",name:"Adeyemi",surname:"Ojutalayo Adeeyo",slug:"adeyemi-ojutalayo-adeeyo",fullName:"Adeyemi Ojutalayo Adeeyo"},{id:"354613",title:"MSc.",name:"Mercy",surname:"Adewumi Alabi",slug:"mercy-adewumi-alabi",fullName:"Mercy Adewumi Alabi"},{id:"354615",title:"MSc.",name:"Tshianeo Mellda",surname:"Ndou",slug:"tshianeo-mellda-ndou",fullName:"Tshianeo Mellda Ndou"},{id:"354616",title:"Prof.",name:"John O.",surname:"Odiyo",slug:"john-o.-odiyo",fullName:"John O. Odiyo"},{id:"427802",title:"Mr.",name:"Hosana Dumisani",surname:"Mkoyi",slug:"hosana-dumisani-mkoyi",fullName:"Hosana Dumisani Mkoyi"},{id:"427803",title:"Dr.",name:"Daniso",surname:"Beswa",slug:"daniso-beswa",fullName:"Daniso Beswa"}],corrections:null},{id:"77299",title:"Health Benefits and Functional and Medicinal Properties of Some Common Indian Spices",doi:"10.5772/intechopen.98676",slug:"health-benefits-and-functional-and-medicinal-properties-of-some-common-indian-spices",totalDownloads:300,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:1,abstract:"India is the largest producer and consumer of some important common spices. Major Indian spices include pepper, cardamom, ginger, turmeric and chilies. Commercial cultivation in India is undertaken on 27 spices besides the herbal spices. Spices and herbs are mostly used as seasonings to impart flavors, pungency, aroma and color in the food. In addition, spices enhances shelf life of the food by preventing and delaying the spoilage and by preserving the sensory attributes of food products. Spices contain several important phytochemicals like aromatic compounds, essential oils, phenolics and pigments which imparts characteristic flavor and aroma and gives a herbal appeal to the food and beverages and enhances their consumer acceptability. In addition the active components of these herbs and spices are endowed with tremendous functional properties and medicinal values providing several health benefits and immunity. The era of Covid-19 has seen spiked consumption of spices and herbs based health drinks and concoctions for providing these health benefits and immunity. The present chapter deals with the characteristics of some important Indian spices, their usages, active components present in them along with exploring their health benefits, functional and immunomodulant properties.",signatures:"Vinod Kumar Paswan, Chandra Shekhar Singh, Garima Kukreja, Durga Shankar Bunkar and Basant Kumar Bhinchhar",downloadPdfUrl:"/chapter/pdf-download/77299",previewPdfUrl:"/chapter/pdf-preview/77299",authors:[{id:"213720",title:"Dr.",name:"Chandra Shekhar",surname:"Singh",slug:"chandra-shekhar-singh",fullName:"Chandra Shekhar Singh"},{id:"220872",title:"Dr.",name:"Vinod Kumar",surname:"Paswan",slug:"vinod-kumar-paswan",fullName:"Vinod Kumar Paswan"},{id:"420815",title:"Ms.",name:"Garima",surname:"Kukreja",slug:"garima-kukreja",fullName:"Garima Kukreja"},{id:"420817",title:"Mr.",name:"Durga Shankar",surname:"Bunkar",slug:"durga-shankar-bunkar",fullName:"Durga Shankar Bunkar"},{id:"420818",title:"Dr.",name:"Basant Kumar",surname:"Bhinchhar",slug:"basant-kumar-bhinchhar",fullName:"Basant Kumar Bhinchhar"}],corrections:null},{id:"77374",title:"Important Medicinal Plants in Ethiopia: A Review in Years 2015–2020",doi:"10.5772/intechopen.97937",slug:"important-medicinal-plants-in-ethiopia-a-review-in-years-2015-2020",totalDownloads:299,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Many studies on medicinal plants have been taking place in different parts of Ethiopia and the people use them for the preparation of traditional herbal medicine. The purpose of the current study is to review the assessment of the medicinal plants used in Ethiopia, to compile the components used, the method of preparation, the medical uses, and the compilation of the number of medicinal plants in 2015–2020. This review paper took place in the years 2015 to 2020 from the published papers. Various databases, such as Science Direct, PubMed, and Google Scholar, have been searched. The data were analyzed using frequency, percentages, charts, and numbers using the Microsoft Excel spreadsheet 2010. In Ethiopia, a total of 4,007 medicinal plants were identified from different areas by different authors in the years 2015–2020. But, from this total number of identified medicinal plants, there was a similarity between types of plant species. Therefore, this total result has present similarities in plant species and types found in different areas. In 2015, a total of 1,062 medicinal plants were identified from different areas by different authors. Similarly, 315, 613, 944, 341, 732 medicinal plants were identified by different authors in different study areas in the years 2016, 2017, 2018, 2019, and 2020 respectively. The years 2015 and 2018 were the years many plants of medicinal value were documented. The growth forms of medicinal plants were analyzed from 2015 to 2020 in the different study areas with different authors but with the same year and valued for each year and put the average one. To calculate the 2015 growth form of medicinal plants for example to calculate herbs, add all herbs identified by different authors in the same year, and take the average one. This method applied to all growth forms of medicinal plants each year. In all years (2015–2020) the dominant growth forms were herbs. The highest average of growth form was herb in the year 2020 which is 44.2%. In all years the least growth form was a climber. In all growth forms, the parts used for medicine were identified. Add each medicinal plant’s parts in the same year and then take the average for all years. In 2020 year, the traditional healers mostly used leaves (56.3%) for the preparation of remedy. In general, in all year leaves was dominant for the preparation of remedy. Oral and dermal ways of the route of administration were the most important in medicinal plants to treat directly different ailments. The route of administration was varying in percentage from year to year and also, a place to place according to the potential of traditional healers and type of diseases. But, different study areas and years showed that oral administration was the dominant one. In 2019, most of the prepared remedy was taken orally. Crushing was the most important and more cited in the preparation of remedy in the year 2015–2020. Also, powdering, boiling, chewing, concoction, grinding, direct and immediate, chopping, squeezing, decoction, boiling/unprocessed use, liquid form, Homogenizing in water, heating, cooking, smoking, and fumigation are common methods of preparation of remedy. In general, this review highlights the situation of Ethiopian traditional medicinal plants associated with their knowledge from years to years. In addition, this review paper plays an important role in the extraction of potential medicinal plants to discover new drugs through detailed researches in the future.",signatures:"Abebe Ayele Haile",downloadPdfUrl:"/chapter/pdf-download/77374",previewPdfUrl:"/chapter/pdf-preview/77374",authors:[{id:"356229",title:"M.Sc.",name:"Abebe",surname:"Ayele Haile",slug:"abebe-ayele-haile",fullName:"Abebe Ayele Haile"}],corrections:null},{id:"77905",title:"Curcuminoids: The Novel Molecules of Nature",doi:"10.5772/intechopen.99201",slug:"curcuminoids-the-novel-molecules-of-nature",totalDownloads:157,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Curcuminoids inactivate Nuclear Factor-Kappa B (NF-κB), a key pro-inflammatory transcription factor which is involved in inflammation and immune response in diseases like cancer. NF-κB activation is necessary to determine tumor microenvironment which controls migration and metastatis of cancer cells through chemokines and their receptors and involvement of some cell adhesion molecules. Therefore inhibition of NF-κB by curcuminoids could be a new approach in treatment of cancer by immune modulation. Curcuminoids are not bioavailable and therefore there were problems in efficacy. Now by using bioavailable curcuminoid formulations the problem has been resolved to a great extent. Out of 49 placebo controlled double blind clinical trials using curcuminoids, 17 have been found to be successful. Therefore curcuminoids could be developed as an adjunct therapy for diseases like cancer to save human life.",signatures:"Sitabja Mukherjee and Santosh K. Kar",downloadPdfUrl:"/chapter/pdf-download/77905",previewPdfUrl:"/chapter/pdf-preview/77905",authors:[{id:"356361",title:"Prof.",name:"Santosh Kumar",surname:"Kar",slug:"santosh-kumar-kar",fullName:"Santosh Kumar Kar"},{id:"426483",title:"Dr.",name:"Sitabja",surname:"Mukherjee",slug:"sitabja-mukherjee",fullName:"Sitabja Mukherjee"}],corrections:null},{id:"77972",title:"Herbs and Spices—New Processing Technologies. Syzygium aromaticum: Medicinal Properties and Phytochemical Screening",doi:"10.5772/intechopen.99199",slug:"herbs-and-spices-new-processing-technologies-em-syzygium-aromaticum-em-medicinal-properties-and-phyt",totalDownloads:128,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"All over the world, Plants have found to be a valuable source of herbs and spices for a long period of time to maintain the human health. Varieties of herbs and spices have been used to impart an aroma and taste to food for last few centuries. Several applications of plants species have been reported as antioxidative, anti-inflammatory, antidiabetic, antihypertensive and antimicrobial activities. Currently efforts are focused on their scientific merits, to provide science-based evidence for their traditional uses and to develop either functional foods or nutraceutical behavior. India is well recognized all over the world for their variety of herbs, spices and medicinal biodiversity. The WHO has listed more than 21000 plants, which are used for their medicinal purposes either in the form of essential oil or in the form of flavor. Among these, more than 2500 species and herbs are found in India, however; among them more than 150 species are used commercially on large scale. In India, the use of spices and herbs in the form of essential oil or in the form of flavor are traditionally used in routine treatment. For example, Curcumin which is found in turmeric are frequently used in medical facilities to wound healing, rheumatic disorders, and gastrointestinal symptoms etc.",signatures:"Vikrant Kumar, Deepak Mishra, Mukesh Chandra Joshi, Priyanka Mishra and Megha Tanwar",downloadPdfUrl:"/chapter/pdf-download/77972",previewPdfUrl:"/chapter/pdf-preview/77972",authors:[{id:"353149",title:"Dr.",name:"Vikrant",surname:"Kumar",slug:"vikrant-kumar",fullName:"Vikrant Kumar"},{id:"426459",title:"Dr.",name:"Deepak",surname:"Mishra",slug:"deepak-mishra",fullName:"Deepak Mishra"},{id:"426460",title:"Dr.",name:"Mukesh",surname:"Chandra Joshi",slug:"mukesh-chandra-joshi",fullName:"Mukesh Chandra Joshi"},{id:"426461",title:"Dr.",name:"Priyanka",surname:"Mishra",slug:"priyanka-mishra",fullName:"Priyanka Mishra"},{id:"426462",title:"Dr.",name:"Megha",surname:"Tanwar",slug:"megha-tanwar",fullName:"Megha Tanwar"}],corrections:null},{id:"78276",title:"Garlic as a Potential Nominee in Functional Food Industry",doi:"10.5772/intechopen.99819",slug:"garlic-as-a-potential-nominee-in-functional-food-industry",totalDownloads:118,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Functional and nutraceuticals products provide a bigger prospect to one’s health by permitting health costs and supporting economic growth in lower and middle developed countries. Because of this reason, mostly diversion of people is going towards functional food and these Phyto-based foods are turning out to be popular universal in the red to the number of statements from researchers for their therapeutic applications. Garlic is one of the ancient vegetables that is used worldwide in different aspects which includes seasoning, culinary purposes, flavoring, and medical purposes. The consumption of garlic word wide increases due to its convenience, tackiness, health benefits, and low side effects. Garlic has been utilized for thousands of years because of its rich active components, phytochemicals, and other Sulfur containing components. It has so much rich history to contribute to the food industry. It has been used as a food stabilizer to prevent the development of pathogens to the prevention of many diseases. The claimed vigor reimbursements of garlic are abundant, including, anticarcinogenic, antibiotic, anti-hypertensive, and cholesterol-lowering properties, the risk of cardiovascular disease lowering the effects of hypolipidemic, antithrombotic, anti-diabetic, antioxidant, antimicrobial, immunomodulatory, antimutagenic, and prebiotic activities. The present attempt of the chapter is to explore garlic history along with its active component’s involvement in the prevention of diseases and threats.",signatures:"Mavra Javed, Waqas Ahmed, Rehan Mian and Abdul Momin Rizwan Ahmad",downloadPdfUrl:"/chapter/pdf-download/78276",previewPdfUrl:"/chapter/pdf-preview/78276",authors:[{id:"356372",title:"Ph.D. Student",name:"Mavra",surname:"Javed",slug:"mavra-javed",fullName:"Mavra Javed"},{id:"357356",title:"Dr.",name:"Waqas",surname:"Ahmed",slug:"waqas-ahmed",fullName:"Waqas Ahmed"},{id:"357359",title:"Dr.",name:"Abdul",surname:"Momin Rizwan Ahmad",slug:"abdul-momin-rizwan-ahmad",fullName:"Abdul Momin Rizwan Ahmad"},{id:"426977",title:"Mr.",name:"Rehan",surname:"Mian",slug:"rehan-mian",fullName:"Rehan Mian"}],corrections:null},{id:"77388",title:"Phyto-Potential of Allium cepa and Allium sativum",doi:"10.5772/intechopen.98374",slug:"phyto-potential-of-em-allium-cepa-em-and-em-allium-sativum-em-",totalDownloads:157,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Garlic and onion are either cooked like a vegetable because of their green leaves or are also used as a condiment. Many scientific studies affirm the positives of both for their anti-inflammatory, antioxidant, and antimicrobial potential. Moreover, garlic and onion are regularly employed to treat cardiovascular illnesses, strokes, atherosclerosis, hypertension, hyperlipidemias, and thrombosis, and are also proved effective against Alzheimer’s, diabetes, and cancers. Here we have compiled a piece of information regarding the compounds present in garlic and onion along with their pharmacological properties. Although much more studies are required to refine the utilization and enhance garlic and medicine’s effectiveness. We hope this work will provide helpful information regarding their pharmacological aspects.",signatures:"Rubi Gupta and Prashant Kaushik",downloadPdfUrl:"/chapter/pdf-download/77388",previewPdfUrl:"/chapter/pdf-preview/77388",authors:[{id:"311935",title:"Dr.",name:"Prashant",surname:"Kaushik",slug:"prashant-kaushik",fullName:"Prashant Kaushik"},{id:"420021",title:"Dr.",name:"Rubi",surname:"Gupta",slug:"rubi-gupta",fullName:"Rubi Gupta"}],corrections:null},{id:"78065",title:"Meticulous Endorsement of Black Seed and Jambolana: A Scientific Review",doi:"10.5772/intechopen.99225",slug:"meticulous-endorsement-of-black-seed-and-jambolana-a-scientific-review",totalDownloads:118,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The repository of traditional, historical and cultural heritage of natural prophylactic medicine to treat different disease, disorder and its aliment is limitless and time-immemorial. As per the hadith narrated by Ibn Abbas (RA), Prophet Muhammed specifically mentioned about Sulayman (AS) recorded the name and use of many herbal medicinal remedies after construction of his castle (Ibn Asakri’s Mukhtasar Tareekh Dimashq 3.393), in addition to it, Prophet Muhammed use to recommend 65 different herbal prophylactic medicines which are scientifically proved to be highly effective against almost all types of ailments, among this repository of 65, while prescribing the NS Prophet Muhammed narrated “use this black seeds regularly it is having the properties to cure all disease (ailment) except death (An authentic hadith narrated by Abu Hurayrah (RA) and recorded by Bukhari, Muslim Ahmad Ibn Majah). This in-depth review specially articulated to elaborate phytochemical, pharmacological and mechanistic approach to bring out the properties of not only NS but in addition, it focusing on the important properties of EJ. Preliminarily to say NS claim to have anti-inflammatory, analgesic, hepato-protective, neuro-protective, gastro-protective and other useful activity are due to two important constituents Thymoquinone (TQ) and NS oil (NSO). TQ has interaction with human serum albumin. Seeds containing volatile oils mainly Melanthin showed toxicity at larger doses. Whereas, EJ simultaneously proved its effectiveness underutilized fruit, crops are nutritious bearing wide range of pharmaceuticals properties. EJ fruit is highly perishable and is mainly used for the diabetes patients, it is well known as a traditional medicinal plant having essential bioactive compounds which are present in all parts of the plant. The major bioactive compounds present in the EJ roots are phytosterols, flavonoids, carotenoids, myricetin, oxalic acid, gallic acid, citronellol, cyanidin diglucoside, hotrienol, and polyphenols as well as micronutrients having many health benefits. It is also a good source of anthocyanin and effective against numerous health problems and act as chemo-preventive, radioprotective and demonstrating antineoplastic properties. The ripe fruits are pleasant, astringent taste and are eaten either raw or processed into different products mainly vinegar, jam, jellies and squash. The jambolana seed contains alkaloid, jambosine, and glycoside jambolin or antimellin. To be concluded, NS and EJ both bearing similar therapeutic and pharmacological endorsement with different remarkable biological active molecule, which will become future reference to find out the natural way to cure untreatable disease and its disorder such as HIV-Aids, Cancer and recent outbreak, etc. according to narration made by Prophet Muhammed .",signatures:"Nikhat Farhana",downloadPdfUrl:"/chapter/pdf-download/78065",previewPdfUrl:"/chapter/pdf-preview/78065",authors:[{id:"352421",title:"Dr.",name:"Nikhat",surname:"Farhana",slug:"nikhat-farhana",fullName:"Nikhat Farhana"}],corrections:null},{id:"76996",title:"Garlic in Traditional Indian Medicine (Ayurveda) for Health and Healing",doi:"10.5772/intechopen.97495",slug:"garlic-in-traditional-indian-medicine-ayurveda-for-health-and-healing",totalDownloads:220,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Traditional Indian Medicine (TIM)- Ayurveda is a Sanskrit Language word, which signifies “true knowledge of life”. It is recognized as one of the oldest Traditional health care systems of the World by World Health Organization. In fact, it was a main stream health care system till the introduction of convention medicine in India. Plant, animal and mineral origin natural substances are used in Ayurveda for health and healing. Of them, Garlic is one of the plant origin substances. Garlic is known as Lasuna, which signifies, destroyer of diseases. The fresh plants of Garlic are used as edible food substance and also the dried cloves are on ripening to alleviate the disorders rationally in TIM. Garlic is recommended as physical strength promoting, intellect promoting and as aphrodisiac to maintain healthy state of life. Its properties like- unctuous, hot, pungent, heavy has been described to alleviates skin diseases, intra abdominal tumor, chronic rhinitis, hemicranias, epilepsy, fainting etc. Its continuous use causes internal hemorrhage. The medicated milk, medicated oil preparation are used orally as well topically. A number of pharmaceutical forms are seen in more than 3000 years old original scriptures of Ayurveda and also in later works as it was in use by successive generation in India. A comprehensive review on Garlic is highlighted here, including original references with scientific evidences.",signatures:"Vinod Kumar Joshi and Apurva Joshi",downloadPdfUrl:"/chapter/pdf-download/76996",previewPdfUrl:"/chapter/pdf-preview/76996",authors:[{id:"290412",title:"Prof.",name:"Vinod Kumar",surname:"Joshi",slug:"vinod-kumar-joshi",fullName:"Vinod Kumar Joshi"},{id:"356261",title:"Dr.",name:"Apurva",surname:"Joshi",slug:"apurva-joshi",fullName:"Apurva Joshi"}],corrections:null},{id:"78215",title:"Pinaceae Species: Spruce, Pine and Fir as a New Culinary Herb and Spice",doi:"10.5772/intechopen.99280",slug:"pinaceae-species-spruce-pine-and-fir-as-a-new-culinary-herb-and-spice",totalDownloads:136,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The Pinaceae family has traditionally been used as medicine, resorted to as a famine food and for ornamental purposes as Christmas trees. In the last few years numerous restaurants have been using different species of Pinaceae family as a garnish or an aromatic spice, using them in different culinary applications like oils and infusions to flavor dressings and broths. Abies grandis (Grand fir), Pseudotsuga menziesii (Douglas fir), Pinus sylvestris (Scots pine) and Picea abies (Norway spruce) were researched on taxonomy, habitats and non-edible uses, culinary traditions, health and nutritional properties, aroma profile. The main compounds in Pinaceae family are monoterpenes, oxygenated monoterpenes, sesquiterpenes, oxygenate sesquiterpenes, diterpenes and hydrocarbons, especially α-β-pinene, limonene, α-terpinene, and even bornyl acetate, responsible for aroma compounds such as citrusy-, woody-, herbal-, or piney aromas. Modern gastronomy uses, sensory analysis and culinary applications were applied for demonstrating the possibilities on modern culinary application in this novel yet traditional spice.",signatures:"Nabila Rodríguez Valerón, Diego Prado Vásquez and Rasmus Munk",downloadPdfUrl:"/chapter/pdf-download/78215",previewPdfUrl:"/chapter/pdf-preview/78215",authors:[{id:"355150",title:"Associate Prof.",name:"Diego",surname:"Prado Vásquez",slug:"diego-prado-vasquez",fullName:"Diego Prado Vásquez"},{id:"424412",title:"Mr.",name:"Nabila",surname:"Rodríguez Valerón",slug:"nabila-rodriguez-valeron",fullName:"Nabila Rodríguez Valerón"},{id:"424414",title:"Mr.",name:"Rasmus",surname:"Munk",slug:"rasmus-munk",fullName:"Rasmus Munk"}],corrections:null},{id:"78252",title:"Genetic Resources of The Universal Flavor, Vanilla",doi:"10.5772/intechopen.99043",slug:"genetic-resources-of-the-universal-flavor-vanilla",totalDownloads:144,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Commercially cultivated vanilla (V. planifolia) is native to Mexico and its cultivation and breeding programmes face major bottlenecks. This study reports presence of important agronomic characters in two important and endangered species of Vanilla, V. aphylla and V. pilifera, indigenous to India. V. aphylla was tolerant to Fusarium wilt and had longer flower life than the cultivated vanilla. V. pilifera flowers were fragrant, showed signs of insect pollination and had large fruit size. The species were amenable to interspecific hybridization and successful reciprocal crosses were done. Sequence similarity studies indicated the clustering of leafy and leafless species separately.",signatures:"Minoo Divakaran and N.T. Fathima Rafieah",downloadPdfUrl:"/chapter/pdf-download/78252",previewPdfUrl:"/chapter/pdf-preview/78252",authors:[{id:"356055",title:"Dr.",name:"Minoo",surname:"Divakaran",slug:"minoo-divakaran",fullName:"Minoo Divakaran"},{id:"423667",title:"Ms.",name:"N.T.",surname:"Fathima Rafieah",slug:"n.t.-fathima-rafieah",fullName:"N.T. Fathima Rafieah"}],corrections:null},{id:"77625",title:"Herbs and Spices Fortified Functional Dairy Products",doi:"10.5772/intechopen.98775",slug:"herbs-and-spices-fortified-functional-dairy-products",totalDownloads:366,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Recently, an increased interest in exploiting the functional and medicinal health attributes of herbs and spices has been observed worldwide among the health conscious consumers to preserve and promote the health and nutrition and immunity particularly during the Covid-19 pandemic era. Fortification of dairy products with these herbs and spices so as to exploit the functional and medicinal attributes have also gained momentum. Herbs and spices are rich source of bioactive compounds such as anti-oxidants, vitamins, micro- and macro-minerals, phytochemicals like flavonoids, alkaloids, glycosides, tannins, essential oils, coumarin, organic acids, phenols and saponins. Milk and other dairy products have been popular compatible vehicles for delivering functional, nutritional and other health benefits of phytochemicals of herbs and spices among the consumers. This chapter explores the quality and functional attributes of herbs and spices fortified dairy products such as herbal spiked milk, curd and yoghurts, paneer, cheese and ice creams and other dairy products.",signatures:"Vinod Kumar Paswan, Hency Rose, Chandra Shekhar Singh, S. Yamini and Aman Rathaur",downloadPdfUrl:"/chapter/pdf-download/77625",previewPdfUrl:"/chapter/pdf-preview/77625",authors:[{id:"213720",title:"Dr.",name:"Chandra Shekhar",surname:"Singh",slug:"chandra-shekhar-singh",fullName:"Chandra Shekhar Singh"},{id:"220872",title:"Dr.",name:"Vinod Kumar",surname:"Paswan",slug:"vinod-kumar-paswan",fullName:"Vinod Kumar Paswan"},{id:"420811",title:"Ms.",name:"Hency",surname:"Rose",slug:"hency-rose",fullName:"Hency Rose"},{id:"420812",title:"Ms.",name:"Yamini",surname:"S",slug:"yamini-s",fullName:"Yamini S"},{id:"420814",title:"Mr.",name:"Aman",surname:"Rathaur",slug:"aman-rathaur",fullName:"Aman Rathaur"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"542",title:"A Compendium of Essays on Alternative Therapy",subtitle:null,isOpenForSubmission:!1,hash:"a805c1d2d8449dcecd52eb7a48d2e6b1",slug:"a-compendium-of-essays-on-alternative-therapy",bookSignature:"Arup Bhattacharya",coverURL:"https://cdn.intechopen.com/books/images_new/542.jpg",editedByType:"Edited by",editors:[{id:"66982",title:"Dr.",name:"Arup",surname:"Bhattacharya",slug:"arup-bhattacharya",fullName:"Arup Bhattacharya"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6302",title:"Herbal Medicine",subtitle:null,isOpenForSubmission:!1,hash:"b70a98c6748d0449a6288de73da7b8d9",slug:"herbal-medicine",bookSignature:"Philip F. Builders",coverURL:"https://cdn.intechopen.com/books/images_new/6302.jpg",editedByType:"Edited by",editors:[{id:"182744",title:"Dr.",name:"Philip",surname:"Builders",slug:"philip-builders",fullName:"Philip Builders"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"631",title:"Quality Control of Herbal Medicines and Related Areas",subtitle:null,isOpenForSubmission:!1,hash:"5ced81d454b4a5ded2a0aa02e0d7621d",slug:"quality-control-of-herbal-medicines-and-related-areas",bookSignature:"Yukihiro Shoyama",coverURL:"https://cdn.intechopen.com/books/images_new/631.jpg",editedByType:"Edited by",editors:[{id:"35812",title:"Prof.",name:"Yukihiro",surname:"Shoyama",slug:"yukihiro-shoyama",fullName:"Yukihiro Shoyama"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"643",title:"Recent Advances in Theories and Practice of Chinese Medicine",subtitle:null,isOpenForSubmission:!1,hash:"499a7fabf489d2502de4616a4c7f3da0",slug:"recent-advances-in-theories-and-practice-of-chinese-medicine",bookSignature:"Haixue Kuang",coverURL:"https://cdn.intechopen.com/books/images_new/643.jpg",editedByType:"Edited by",editors:[{id:"44740",title:"Prof.",name:"Haixue",surname:"Kuang",slug:"haixue-kuang",fullName:"Haixue Kuang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5612",title:"Aromatic and Medicinal Plants",subtitle:"Back to Nature",isOpenForSubmission:!1,hash:"ccf7987200bfc541e2e56bb138de86f3",slug:"aromatic-and-medicinal-plants-back-to-nature",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/5612.jpg",editedByType:"Edited by",editors:[{id:"54719",title:"Prof.",name:"Hany",surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2975",title:"Complementary Therapies for the Contemporary Healthcare",subtitle:null,isOpenForSubmission:!1,hash:"604c4ba43197c3ba1506c55c763d4ca7",slug:"complementary-therapies-for-the-contemporary-healthcare",bookSignature:"Marcelo Saad and Roberta de Medeiros",coverURL:"https://cdn.intechopen.com/books/images_new/2975.jpg",editedByType:"Edited by",editors:[{id:"51991",title:"Prof.",name:"Marcelo",surname:"Saad",slug:"marcelo-saad",fullName:"Marcelo Saad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5494",title:"Chinese Medical Therapies for Diabetes, Infertility, Silicosis and the Theoretical Basis",subtitle:null,isOpenForSubmission:!1,hash:"7b3b6a2700d7fd0511770bf77290a422",slug:"chinese-medical-therapies-for-diabetes-infertility-silicosis-and-the-theoretical-basis",bookSignature:"Xing-Tai Li",coverURL:"https://cdn.intechopen.com/books/images_new/5494.jpg",editedByType:"Edited by",editors:[{id:"73821",title:"Dr.",name:"Xing-Tai",surname:"Li",slug:"xing-tai-li",fullName:"Xing-Tai Li"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6994",title:"Tea",subtitle:"Chemistry and Pharmacology",isOpenForSubmission:!1,hash:"e6241cd52834161ac64d4a7b2a812796",slug:"tea-chemistry-and-pharmacology",bookSignature:"Gonçalo Justino",coverURL:"https://cdn.intechopen.com/books/images_new/6994.jpg",editedByType:"Edited by",editors:[{id:"76687",title:"Dr.",name:"Gonçalo",surname:"Justino",slug:"goncalo-justino",fullName:"Gonçalo Justino"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9108",title:"Medicinal Plants",subtitle:"Use in Prevention and Treatment of Diseases",isOpenForSubmission:!1,hash:"7d0c52af195da3322be63610d6567019",slug:"medicinal-plants-use-in-prevention-and-treatment-of-diseases",bookSignature:"Bassam Abdul Rasool Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/9108.jpg",editedByType:"Edited by",editors:[{id:"155124",title:"Dr.",name:"Bassam",surname:"Hassan",slug:"bassam-hassan",fullName:"Bassam Hassan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"72959",slug:"erratum-driving-control-technologies-of-new-high-efficient-motors",title:"Erratum - Driving Control Technologies of New High-Efficient Motors",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/72959.pdf",downloadPdfUrl:"/chapter/pdf-download/72959",previewPdfUrl:"/chapter/pdf-preview/72959",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/72959",risUrl:"/chapter/ris/72959",chapter:{id:"68411",slug:"driving-control-technologies-of-new-high-efficient-motors",signatures:"Chang-Ming Liaw, Min-Ze Lu, Ping-Hong Jhou and Kuan-Yu Chou",dateSubmitted:"April 1st 2019",dateReviewed:"July 2nd 2019",datePrePublished:"August 22nd 2019",datePublished:"March 25th 2020",book:{id:"9290",title:"Applied Electromechanical Devices and Machines for Electric Mobility Solutions",subtitle:null,fullTitle:"Applied Electromechanical Devices and Machines for Electric Mobility Solutions",slug:"applied-electromechanical-devices-and-machines-for-electric-mobility-solutions",publishedDate:"March 25th 2020",bookSignature:"Adel El-Shahat and Mircea Ruba",coverURL:"https://cdn.intechopen.com/books/images_new/9290.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"193331",title:"Dr.",name:"Adel",middleName:null,surname:"El-Shahat",slug:"adel-el-shahat",fullName:"Adel El-Shahat"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"37616",title:"Prof.",name:"Chang-Ming",middleName:null,surname:"Liaw",fullName:"Chang-Ming Liaw",slug:"chang-ming-liaw",email:"cmliaw@ee.nthu.edu.tw",position:null,institution:null},{id:"180324",title:"Dr.",name:"Kai-Wei",middleName:null,surname:"Hu",fullName:"Kai-Wei Hu",slug:"kai-wei-hu",email:"kaiweihu@hotmail.com.tw",position:null,institution:{name:"National Tsing Hua University",institutionURL:null,country:{name:"Taiwan"}}},{id:"308019",title:"MSc.",name:"Jia-Hsiang",middleName:null,surname:"Zhuang",fullName:"Jia-Hsiang Zhuang",slug:"jia-hsiang-zhuang",email:"abc0929352983@yahoo.com.tw",position:null,institution:{name:"National Tsing Hua University",institutionURL:null,country:{name:"Taiwan"}}},{id:"308021",title:"MSc.",name:"Shih-Wei",middleName:null,surname:"Su",fullName:"Shih-Wei Su",slug:"shih-wei-su",email:"nthu18356743@gmail.com",position:null,institution:{name:"National Tsing Hua University",institutionURL:null,country:{name:"Taiwan"}}}]}},chapter:{id:"68411",slug:"driving-control-technologies-of-new-high-efficient-motors",signatures:"Chang-Ming Liaw, Min-Ze Lu, Ping-Hong Jhou and Kuan-Yu Chou",dateSubmitted:"April 1st 2019",dateReviewed:"July 2nd 2019",datePrePublished:"August 22nd 2019",datePublished:"March 25th 2020",book:{id:"9290",title:"Applied Electromechanical Devices and Machines for Electric Mobility Solutions",subtitle:null,fullTitle:"Applied Electromechanical Devices and Machines for Electric Mobility Solutions",slug:"applied-electromechanical-devices-and-machines-for-electric-mobility-solutions",publishedDate:"March 25th 2020",bookSignature:"Adel El-Shahat and Mircea Ruba",coverURL:"https://cdn.intechopen.com/books/images_new/9290.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"193331",title:"Dr.",name:"Adel",middleName:null,surname:"El-Shahat",slug:"adel-el-shahat",fullName:"Adel El-Shahat"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"37616",title:"Prof.",name:"Chang-Ming",middleName:null,surname:"Liaw",fullName:"Chang-Ming Liaw",slug:"chang-ming-liaw",email:"cmliaw@ee.nthu.edu.tw",position:null,institution:null},{id:"180324",title:"Dr.",name:"Kai-Wei",middleName:null,surname:"Hu",fullName:"Kai-Wei Hu",slug:"kai-wei-hu",email:"kaiweihu@hotmail.com.tw",position:null,institution:{name:"National Tsing Hua University",institutionURL:null,country:{name:"Taiwan"}}},{id:"308019",title:"MSc.",name:"Jia-Hsiang",middleName:null,surname:"Zhuang",fullName:"Jia-Hsiang Zhuang",slug:"jia-hsiang-zhuang",email:"abc0929352983@yahoo.com.tw",position:null,institution:{name:"National Tsing Hua University",institutionURL:null,country:{name:"Taiwan"}}},{id:"308021",title:"MSc.",name:"Shih-Wei",middleName:null,surname:"Su",fullName:"Shih-Wei Su",slug:"shih-wei-su",email:"nthu18356743@gmail.com",position:null,institution:{name:"National Tsing Hua University",institutionURL:null,country:{name:"Taiwan"}}}]},book:{id:"9290",title:"Applied Electromechanical Devices and Machines for Electric Mobility Solutions",subtitle:null,fullTitle:"Applied Electromechanical Devices and Machines for Electric Mobility Solutions",slug:"applied-electromechanical-devices-and-machines-for-electric-mobility-solutions",publishedDate:"March 25th 2020",bookSignature:"Adel El-Shahat and Mircea Ruba",coverURL:"https://cdn.intechopen.com/books/images_new/9290.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"193331",title:"Dr.",name:"Adel",middleName:null,surname:"El-Shahat",slug:"adel-el-shahat",fullName:"Adel El-Shahat"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"10479",leadTitle:null,title:"21st Century Advanced Carbon Materials for Engineering Applications",subtitle:"A Comprehensive Handbook",reviewType:"peer-reviewed",abstract:"Advanced carbon materials such as graphene, fullerenes, hierarchical carbon, and carbon nanotubes (CNTs) have exceptional physical properties, making them useful for several applications in fields ranging from energy and industry to electronics and drug delivery. This book includes comprehensive information on fabrication, emerging physical properties, and technological applications of advanced carbon materials. Over three sections, chapters cover such topics as advanced carbon materials in engineering, conjugation of graphene with other 2D materials, fabrication of CNTs and their use in tissue engineering and orthopaedics, and advanced carbon materials for sustainable applications, among others.",isbn:"978-1-78985-924-9",printIsbn:"978-1-78985-912-6",pdfIsbn:"978-1-78985-991-1",doi:"10.5772/intechopen.92494",price:119,priceEur:129,priceUsd:155,slug:"21st-century-advanced-carbon-materials-for-engineering-applications-a-comprehensive-handbook",numberOfPages:130,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"712d04d43dbe1dca7dec9fcc08bc8852",bookSignature:"Mujtaba Ikram and Asghari Maqsood",publishedDate:"October 13th 2021",coverURL:"https://cdn.intechopen.com/books/images_new/10479.jpg",keywords:null,numberOfDownloads:1803,numberOfWosCitations:0,numberOfCrossrefCitations:4,numberOfDimensionsCitations:10,numberOfTotalCitations:14,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"August 28th 2020",dateEndSecondStepPublish:"September 25th 2020",dateEndThirdStepPublish:"November 24th 2020",dateEndFourthStepPublish:"February 12th 2021",dateEndFifthStepPublish:"April 13th 2021",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"2 years",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:"A visiting scholar at the Abdus Salam International Center for Theoretical Physics (ICTP)-Italy from time to time, Dr. Ikram was selected among two young scientists from South Asia for TWAS science diplomacy, which was held in Trieste Italy 2013 and in 2015, he was also awarded CAS-TWAS green technology award followed by CAS-TWAS green chemistry and technology (GCT) award for his guest lectures in 2017.",coeditorOneBiosketch:"A dean of the Faculty of Basics and Applied Sciences, Air University, Islamabad, Pakistan with over 40 years of experience in research of advanced materials. Prof. Maqsood has 212 research publications, including 180 journal publications and 4 book chapters. She is a receiver of many national and international awards and is recognized widely for her scientific work.",coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"286820",title:"Dr.",name:"Mujtaba",middleName:null,surname:"Ikram",slug:"mujtaba-ikram",fullName:"Mujtaba Ikram",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bReopQAC/Profile_Picture_1636383457578",biography:"Dr. Mujtaba Ikram has obtained his BS hons. (computational physics), MS (materials and surface engineering) and Ph.D. (material sciences and engineering), respectively. His research interests include nanotechnology, renewable energy, material science and engineering. His work has been cited by scientists from all over the world. He has authored/co- authored number of publications with 100+ cumulative impact factor in world prestigious journals as Advanced materials, RSC advances, Journal of Materials Chemistry C, RSC New Journal of chemistry, Chemcatchem, Journal of alloys and compounds, Applied nanoscience, International Journal of hydrogen energy, Journal of physics and chemistry of solids, Journals of solid state chemistry and many others. He has represented his research in the USA, Italy, Egypt, Germany, Slovenia, China, Hong Kong, Malaysia, UAE and many other countries. He has attended various research training/conferences/workshops on industrial physics, renewable energy, advanced carbon materials and nanotechnology in various parts of the world. He is a frequent visiting scholar at the Abdus Salam International center for theoretical physics (ICTP)-Italy. He has attended training on renewable and sustainable energy, which was organized by world prestigious national renewable energy lab (NREL)-USA and university of colorado at boulder-USA. He has attended AIP Industrial physics forum, ICTP- UNESCO-Italy conferences on energy co sponsored by American Institute of Physics (AIP), I-CAMP-colorado conference-USA, International conference on nanotechnology, biotechnology and spectroscopy (ICNBS)-Egypt, TWAS Energy science diplomacy Conference-Italy, International conference on advanced carbon Materials-Jinan-China and International ICTP nanosystems workshop-Italy. He was selected among two young scientists from south Asia for TWAS science diplomacy, which was held in Trieste Italy, 2013. He has been invited many times as Invited lecturer by CAS-TWAS Beijing. In 2015, he was awarded with CAS-TWAS green technology award. In 2017, he was awarded with CAS-TWAS green chemistry and technology (GCT) award for his guest lectures. He has been awarded with various world prestigious fellowships as CAS- TWAS presidential fellowship 2014, I-CAMP University of Colorado at boulder (USA) fellowship 2012, International center for theoretical physics (ICTP-Italy) participant fellowship (thrice), UNESCO fellowship for nano system workshop (Italy) 2013, Intercontinental advanced materials and photonics university of Cambridge (UK) participant fellowship 2013, Emerging nation science foundation (ENSF) travel fellowship 2012 and NUST foreign research presentation grant 2012.",institutionString:"University of the Punjab",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of the Punjab",institutionURL:null,country:{name:"Pakistan"}}}],coeditorOne:{id:"321219",title:"Dr.",name:"Asghari",middleName:null,surname:"Maqsood",slug:"asghari-maqsood",fullName:"Asghari Maqsood",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00002w6QhQQAU/Profile_Picture_1636447379567",biography:"Professor Emeritus Dr Asghari Maqsood is currently working as an advisor to the vice-chancellor, Air University, Islamabad, Pakistan, where she also served as a founding dean in the Faculty of Basics and Applied Sciences. She has more than forty-eight years of experience in the research of advanced materials. She obtained her MSc from Oxford University, and Ph.D. in Materials Science from Goteborg University, Sweden, along with a diploma from Uppsala University, Sweden. She has more than 250 research publications to her credit including more than 230 journal publications and 4 books, 5 chapters and one edited book.\r\nShe has arranged many international and national conferences and has presented her work as an invited speaker internationally in Bangladesh, China, Iran, Malaysia, Singapore, Sri Lanka, United Kingdom etc. She has been awarded many national and international awards including a Gold Medal from the Pakistan Academy of Sciences (2000), President’s Award for Pride of Performance (2001), HEC Best University Teacher Award (2002), Prime Minister Gold Medal (2004), Izaz-i-Fazeelat for Academic Distinction (2005), and Civil Award Sitara- e- Imtiaz (2010). Professor Maqsood is a fellow of Pakistan Academy of Sciences and Pakistan Nuclear Society. She has supervised more than 130 post graduate theses. Recently, her name appeared among the world's top 2% of scientists on a list by Stanford University, California, USA.",institutionString:"Air University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Air University",institutionURL:null,country:{name:"Pakistan"}}},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"208",title:"Material Science",slug:"nanotechnology-and-nanomaterials-material-science"}],chapters:[{id:"74964",title:"Introductory Chapter: Introduction to Advanced Carbon Materials and Innovative Engineering Applications",slug:"introductory-chapter-introduction-to-advanced-carbon-materials-and-innovative-engineering-applicatio",totalDownloads:176,totalCrossrefCites:0,authors:[{id:"286820",title:"Dr.",name:"Mujtaba",surname:"Ikram",slug:"mujtaba-ikram",fullName:"Mujtaba Ikram"},{id:"321219",title:"Dr.",name:"Asghari",surname:"Maqsood",slug:"asghari-maqsood",fullName:"Asghari Maqsood"},{id:"325636",title:"Prof.",name:"Abdullah Khan",surname:"Durrani",slug:"abdullah-khan-durrani",fullName:"Abdullah Khan Durrani"},{id:"329337",title:"Dr.",name:"Sana",surname:"Arbab",slug:"sana-arbab",fullName:"Sana Arbab"},{id:"343632",title:"Prof.",name:"Khurram",surname:"Shahzad",slug:"khurram-shahzad",fullName:"Khurram Shahzad"},{id:"345882",title:"Dr.",name:"Sadia",surname:"Sharif",slug:"sadia-sharif",fullName:"Sadia Sharif"},{id:"345883",title:"Ms.",name:"Amna",surname:"Saeed",slug:"amna-saeed",fullName:"Amna Saeed"},{id:"345884",title:"Mr.",name:"Muhammad Aamir",surname:"Iqbal",slug:"muhammad-aamir-iqbal",fullName:"Muhammad Aamir Iqbal"}]},{id:"74947",title:"Advanced Carbon Materials: Base of 21st Century Scientific Innovations in Chemical, Polymer, Sensing and Energy Engineering",slug:"advanced-carbon-materials-base-of-21st-century-scientific-innovations-in-chemical-polymer-sensing-an",totalDownloads:289,totalCrossrefCites:2,authors:[{id:"286820",title:"Dr.",name:"Mujtaba",surname:"Ikram",slug:"mujtaba-ikram",fullName:"Mujtaba Ikram"},{id:"321219",title:"Dr.",name:"Asghari",surname:"Maqsood",slug:"asghari-maqsood",fullName:"Asghari Maqsood"},{id:"325636",title:"Prof.",name:"Abdullah Khan",surname:"Durrani",slug:"abdullah-khan-durrani",fullName:"Abdullah Khan Durrani"},{id:"343632",title:"Prof.",name:"Khurram",surname:"Shahzad",slug:"khurram-shahzad",fullName:"Khurram Shahzad"},{id:"325637",title:"Dr.",name:"Muhammad",surname:"Ikram",slug:"muhammad-ikram",fullName:"Muhammad Ikram"},{id:"342880",title:"Dr.",name:"Ali",surname:"Haider",slug:"ali-haider",fullName:"Ali Haider"},{id:"342882",title:"Mr.",name:"Junaid",surname:"Haider",slug:"junaid-haider",fullName:"Junaid Haider"},{id:"343631",title:"Dr.",name:"Ali",surname:"Raza",slug:"ali-raza",fullName:"Ali Raza"},{id:"343633",title:"Dr.",name:"Asim Hassan",surname:"Rizvi",slug:"asim-hassan-rizvi",fullName:"Asim Hassan Rizvi"}]},{id:"76289",title:"Carbon Nanotubes Integrated Hydroxyapatite Nano-Composite for Orthopaedic and Tissue Engineering Applications",slug:"carbon-nanotubes-integrated-hydroxyapatite-nano-composite-for-orthopaedic-and-tissue-engineering-app",totalDownloads:250,totalCrossrefCites:0,authors:[{id:"281461",title:"Ph.D.",name:"Khalid",surname:"Parwez",slug:"khalid-parwez",fullName:"Khalid Parwez"}]},{id:"78704",title:"Advanced Carbon Materials for Sustainable and Emerging Applications",slug:"advanced-carbon-materials-for-sustainable-and-emerging-applications",totalDownloads:212,totalCrossrefCites:0,authors:[{id:"435073",title:"Dr.",name:"Aneeqa",surname:"Bashir",slug:"aneeqa-bashir",fullName:"Aneeqa Bashir"},{id:"435075",title:"Dr.",name:"Azka",surname:"Mehvish",slug:"azka-mehvish",fullName:"Azka Mehvish"},{id:"435076",title:"Dr.",name:"Maria",surname:"Khalil",slug:"maria-khalil",fullName:"Maria Khalil"}]},{id:"74312",title:"Electrochemical Exfoliation of 2D Advanced Carbon Derivatives",slug:"electrochemical-exfoliation-of-2d-advanced-carbon-derivatives",totalDownloads:510,totalCrossrefCites:2,authors:[{id:"325637",title:"Dr.",name:"Muhammad",surname:"Ikram",slug:"muhammad-ikram",fullName:"Muhammad Ikram"},{id:"337345",title:"MSc.",name:"Ali",surname:"Raza",slug:"ali-raza",fullName:"Ali Raza"},{id:"337401",title:"Mr.",name:"Sarfraz",surname:"Ali",slug:"sarfraz-ali",fullName:"Sarfraz Ali"},{id:"337402",title:"Prof.",name:"Salamat",surname:"Ali",slug:"salamat-ali",fullName:"Salamat Ali"}]},{id:"74549",title:"Carbon Nanotubes",slug:"carbon-nanotubes",totalDownloads:367,totalCrossrefCites:0,authors:[{id:"325637",title:"Dr.",name:"Muhammad",surname:"Ikram",slug:"muhammad-ikram",fullName:"Muhammad Ikram"},{id:"342880",title:"Dr.",name:"Ali",surname:"Haider",slug:"ali-haider",fullName:"Ali Haider"},{id:"342882",title:"Mr.",name:"Junaid",surname:"Haider",slug:"junaid-haider",fullName:"Junaid Haider"},{id:"337345",title:"MSc.",name:"Ali",surname:"Raza",slug:"ali-raza",fullName:"Ali Raza"},{id:"337401",title:"Mr.",name:"Sarfraz",surname:"Ali",slug:"sarfraz-ali",fullName:"Sarfraz Ali"},{id:"337402",title:"Prof.",name:"Salamat",surname:"Ali",slug:"salamat-ali",fullName:"Salamat Ali"},{id:"342877",title:"Dr.",name:"Atif",surname:"Shahbaz",slug:"atif-shahbaz",fullName:"Atif Shahbaz"},{id:"342878",title:"Ms.",name:"Haleema",surname:"Ijaz",slug:"haleema-ijaz",fullName:"Haleema Ijaz"},{id:"342881",title:"Mr.",name:"M Tayyab",surname:"Hussain",slug:"m-tayyab-hussain",fullName:"M Tayyab Hussain"},{id:"342883",title:"Mr.",name:"Arsalan",surname:"Ahmed Rafi",slug:"arsalan-ahmed-rafi",fullName:"Arsalan Ahmed Rafi"}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"280415",firstName:"Josip",lastName:"Knapic",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/280415/images/8050_n.jpg",email:"josip@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copy-editing and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6408",title:"Novel Nanomaterials",subtitle:"Synthesis and Applications",isOpenForSubmission:!1,hash:"f3585d338d78e4d31c200d9991b03692",slug:"novel-nanomaterials-synthesis-and-applications",bookSignature:"George Z. Kyzas and Athanasios C. Mitropoulos",coverURL:"https://cdn.intechopen.com/books/images_new/6408.jpg",editedByType:"Edited by",editors:[{id:"152296",title:"Prof.",name:"George",surname:"Kyzas",slug:"george-kyzas",fullName:"George Kyzas"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6833",title:"Chemical Vapor Deposition for Nanotechnology",subtitle:null,isOpenForSubmission:!1,hash:"31d2b0b2a437691b6a657030687b0096",slug:"chemical-vapor-deposition-for-nanotechnology",bookSignature:"Pietro Mandracci",coverURL:"https://cdn.intechopen.com/books/images_new/6833.jpg",editedByType:"Edited by",editors:[{id:"80989",title:"Prof.",name:"Pietro",surname:"Mandracci",slug:"pietro-mandracci",fullName:"Pietro Mandracci"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7640",title:"Perspective of Carbon Nanotubes",subtitle:null,isOpenForSubmission:!1,hash:"8b85a9957fad5206369eadf0c1ffa27d",slug:"perspective-of-carbon-nanotubes",bookSignature:"Hosam El-Din Saleh and Said Moawad Mohamed El-Sheikh",coverURL:"https://cdn.intechopen.com/books/images_new/7640.jpg",editedByType:"Edited by",editors:[{id:"144691",title:"Prof.",name:"Hosam",surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8385",title:"Nanocrystalline Materials",subtitle:null,isOpenForSubmission:!1,hash:"cf72d957868565da82cc4ad919e6c4d7",slug:"nanocrystalline-materials",bookSignature:"Behrooz Movahedi",coverURL:"https://cdn.intechopen.com/books/images_new/8385.jpg",editedByType:"Edited by",editors:[{id:"150371",title:"Prof.",name:"Behrooz",surname:"Movahedi",slug:"behrooz-movahedi",fullName:"Behrooz Movahedi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6218",title:"Carbon Nanotubes",subtitle:"Recent Progress",isOpenForSubmission:!1,hash:"9f38af20209e9d816b7d57ecbba386b9",slug:"carbon-nanotubes-recent-progress",bookSignature:"Mohammed Muzibur Rahman and Abdullah Mohamed Asiri",coverURL:"https://cdn.intechopen.com/books/images_new/6218.jpg",editedByType:"Edited by",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6501",title:"Electrospinning Method Used to Create Functional Nanocomposites Films",subtitle:null,isOpenForSubmission:!1,hash:"c28620c5ccc64e4b32eb9758302a1679",slug:"electrospinning-method-used-to-create-functional-nanocomposites-films",bookSignature:"Tomasz Tański, Pawel Jarka and Wiktor Matysiak",coverURL:"https://cdn.intechopen.com/books/images_new/6501.jpg",editedByType:"Edited by",editors:[{id:"15700",title:"Prof.",name:"Tomasz Arkadiusz",surname:"Tański",slug:"tomasz-arkadiusz-tanski",fullName:"Tomasz Arkadiusz Tański"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7684",title:"Multilayer Thin Films",subtitle:"Versatile Applications for Materials Engineering",isOpenForSubmission:!1,hash:"fd04577df0c895320c3f06d98308ea67",slug:"multilayer-thin-films-versatile-applications-for-materials-engineering",bookSignature:"Sukumar Basu",coverURL:"https://cdn.intechopen.com/books/images_new/7684.jpg",editedByType:"Edited by",editors:[{id:"50632",title:"Prof.",name:"Sukumar",surname:"Basu",slug:"sukumar-basu",fullName:"Sukumar Basu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8446",title:"Zinc Oxide Based Nano Materials and Devices",subtitle:null,isOpenForSubmission:!1,hash:"7c1d14eb8eac769093f8d7a219a3884f",slug:"zinc-oxide-based-nano-materials-and-devices",bookSignature:"Ahmed M. Nahhas",coverURL:"https://cdn.intechopen.com/books/images_new/8446.jpg",editedByType:"Edited by",editors:[{id:"140058",title:"Prof.",name:"Ahmed",surname:"Nahhas",slug:"ahmed-nahhas",fullName:"Ahmed Nahhas"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6960",title:"Flame Retardants",subtitle:null,isOpenForSubmission:!1,hash:"506ea55aeb09b1a47f9113cc66594291",slug:"flame-retardants",bookSignature:"Fahmina Zafar and Eram Sharmin",coverURL:"https://cdn.intechopen.com/books/images_new/6960.jpg",editedByType:"Edited by",editors:[{id:"89672",title:"Dr.",name:"Fahmina",surname:"Zafar",slug:"fahmina-zafar",fullName:"Fahmina Zafar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7652",title:"Nanostructures",subtitle:null,isOpenForSubmission:!1,hash:"ad1e5c5f214960269e89371d1110cbc0",slug:"nanostructures",bookSignature:"Sadia Ameen, M. Shaheer Akhtar and Hyung-Shik Shin",coverURL:"https://cdn.intechopen.com/books/images_new/7652.jpg",editedByType:"Edited by",editors:[{id:"52613",title:"Dr.",name:"Sadia",surname:"Ameen",slug:"sadia-ameen",fullName:"Sadia Ameen"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"65774",title:"Tendon Structure and Classification",doi:"10.5772/intechopen.84622",slug:"tendon-structure-and-classification",body:'
Tendons are dense fibrous tissues that bind the muscles to the bone. They play an important role in the movement by transmitting the contraction force produced by the muscles to the bone they hold. At the same time, their contribution to stability to the joints is extremely important. Although they differ in shape and size depending on the location, the common feature of all is that they can attach to a bone and transmit large loads without deforming them. Although they are structurally sound as they can withstand very high powers due to their function, degeneration and various damages caused by aging can result in loss of muscle strength [1, 2, 3].
Although tendons generally have a very complex structure, they are actually heavily composed of connective tissue and have a small number of cells and rich extracellular matrix, similar to other connective tissue structures. In terms of total tissue volume, while the cellular structure constitutes approximately 20% of total tissue volume, the remaining cells form 80% of the extracellular matrix. As a result of these factors, the cellular structure is mainly 60–85% collagen, 0.2% proteoglycans such as inorganic substances, 2% elastin, and 4.5% other proteins, while the matrix is composed of 55–70% water and the rest of the extracellular matrix consists of proteoglycans [4, 5].
When we look at the structure, tendons are composed of collagen fibrils; they consist of fiber bundles, fascicles, and finally the tendon structure, also known as a group of fascicles. In conclusion, tendons are composed of multiple bundles, fibroblast, and dense linear collagen fibrils, which form the macroscopic structure of tendons and give the appearance of fibrous. In general, connective tissue surrounding the tendons allows some friction. In this way, the ligament around many tendons has a mesotendon that sticks to the tissue and encircles it. This structure also allows the tendon to flush. The connective tissue of low density surrounds tendon fascicles, which is called the endotendon. The fact that tendon fascicles are surrounded by endotendon actually allows tendon bundles to make small slip motion. Endotendon tissue continues in the form of an epitendon covering the tendon surface. When the tendon joins with the muscle, it continues as epimysium in the epitendon muscle. At this point, the muscle-tendon junction must transmit the muscle contraction to the tendon exactly. The tendon adhesion of the muscle occurs when the fibrous tissue layers of the muscle enter the collagen fibers of the tendon into the collagen fibers. In a study conducted by electron microscopy, the position of the muscle cells and tendons is like the fingers of two hands that are locked together. Collagen fibers do not enter the muscle cells, but they bind tightly under the basal membrane. The movement of a normal tendon, the transfer of muscle power for the entire movement of the joints, and the feeding of tendons depend on peritendinous connective tissue. This structure is called the peritendon. These structures form the sheaths, which are very finely organized structures from the loose connective tissue [3, 6].
The cell and matrix compositions of tendons are similar to ligaments and capsules and contain only small differences. In fact, they all have the same cell type and similar vascular and innervation sources. Collagen, elastin, proteoglycan, and noncollagenous proteins combine to form the macromolecular framework of dense fibrous tissues. In all of them, the dominant cell type is fibroblasts. In particular, the cells within the tendons are specific fibroblasts called tenocytes. The main role of these cells is to control cell metabolism (production and degradation of extracellular matrix) and to react to mechanical stimuli applied to the tendon. Especially tensile loads act as a signal for collagen production, and this process is called mechanical transmission. These cells stretch along collagen fibrils in the form of longitudinal arrays where they have a tensile load [7, 8].
The extracellular matrix of tendons is largely composed of collagen fiber network and less proteoglycans, elastin, and other proteins. The main task of these components is to maintain the structure of the tendon and facilitate the biomechanical reaction of the tissue against mechanical loads. An important component of extracellular matrix, proteoglycans, forms less than 1% of the dry weight [9].
The main substance in tendons and ligaments is basically about 0.2% inorganic substances and about 4.5% other proteins. The most effective of inorganic substances are proteoglycans. In addition to prostaglandins with a small amount in the main substance, the most common biomechanical properties are the decorin and cartilage oligomeric matrix protein (COMP) [10].
The protein clusters in the structure are connected to a large portion of the extracellular matrix of tendons, making the matrix a structure similar to the gel. Thanks to this compound, collagen provides spaces and lubrication between microfibrils, while cement-like material also makes the collagen structure of tendons stable and contributes to the resistance of the tissue [3, 11, 12].
The collagen in the tendon structure is found as the main molecule of dense fibrous tissue and forms approximately 70% of dry weight. When examined as collagen type, it is largely composed of Type I (60%) and other types, namely, Types III, IV, V, and VI. Collagen Type-I fibers are capable of withstanding large tensile loads and are found in abundance from the tendon structure, allowing a certain degree of stretch and mechanical deformations of the tendons [13].
According to today’s information, synthesis of collagen in connective tissue begins in the cell membrane of fibroblasts. This synthesis process is similar to that of all connective tissue, although it may differ slightly depending on the type of complex collagen. Therefore, tendons, which contain Type-I collagen, have a process of synthesis and degradation similar to those in the ligaments and bones. From here, with a more detailed look, we can say that synthesizing for collagens in tendon structure begins in the cell membrane of the tenocytes. “Integrin” molecules have an important role in collagen production because they are sensitive to the transmission of mechanical charge from inside the cell to the outside or vice versa. In other words, the integrins are like force sensors and, in particular, detect cell withdrawal, allowing the cell to react to these mechanical stimuli. At the same time, various growth factors contribute to the regulation of this mechanical conversion process [14].
Cross-linkages form between collagen molecules, which are very important for clustering at the fibril level. The cross-links between the fibrils are more complex. And this cross-link structure of collagen fibrils provides the strength of the tissue and thus ensures that it performs the task of the tissue under mechanical loads. In the newly formed collagen, these cross bonds are less in number, soluble in salt or acid solution, and can easily break with heat. As collagen matures, the number of cross bonds that can dissolve and break down decreases and decreases to the minimum level. As a result, organized collagen molecules form microfibril, sub-fibrils, and fibrils. The fibrils are also clustered to form collagen fibers, collagen clusters or fascicles, and the tendon. Tenocytes are arranged between these fascicles and aligned in the direction of the mechanical load [10].
In the cellular structures of tendons, as mentioned above, there is much less amount of elastin than collagen, because the mechanical properties of the tendons depend not only on the architecture and properties of collagen fibers but also on the extent to which this structure contains elastin. However, in tendons, elastin proteins, which usually constitute about 2% of the dry weight, can be up to 70% in elastic bonds such as nuchal ligament and ligamentum flavor. Because the bond has a special function and the nerve roots of the spine, mechanical stresses, stresses, etc. provide stability to the spine [9, 15].
Blood circulation in tendons is very important, because the current circulation of blood directly affects metabolic activity especially during healing. However, blood circulation in tendons is not as rich as muscles and bones, and it accounts for only 1–2% of the extracellular matrix. Therefore, they have a white color when compared to the muscles with a much higher blood vessel density. However, there are a few factors such as the anatomical location, structure, previously damaged condition, and physical activity level of tendons that contribute to blood supply besides the small amount of vascular structure. There are studies that show that blood flow increases in tendons in the case of increasing physical activity in the literature. There are more vascular tendons due to their anatomical position or shape and function. The flushing of tendons is primarily derived from the synovium at the point of attachment to the bone or paratenon. However, some tendons feed on the tendon like the Achilles tendon and the paratenon structure, and some tendons are fed by a true synovial sheath they are surrounded. Bone and tendon adhesion is a layer of cartilage where blood flow cannot pass directly from the bone-tendon compound. Instead, they make anastomosis with the veins on the periosteum and make indirect connections [16].
In contrast, tendons have a very rich neural network and are often innervated from the muscles in which they are associated or from the local cuticle nerves. However, experimental studies on humans and animals have shown that tendons have different characteristics of nerve endings and mechanoreceptors. They play an important role especially for proprioception (position perception) and nociception (pain perception) in joints. In fact, studies have shown that there is internal growth in the nervous and vascular systems during the healing of tendon, which causes chronic pain. Internal growth of the vein is an indicator of the tendon trying to heal, but because of this growth, nerves may feel pain in areas without pain before. This means that the nerves play an important role not only in the proprioception but also in the nociception. Nerve endings are located below the muscle-tendon junction and typically in the bone-tendon junction in the form of Golgi organs, Pacini bodies, and Ruffini endings. Of these, the Golgi organs are only mechanically stimulated by pressure and compression, so that they receive information from the power produced by the muscle. Pacinian bodies are rapidly adaptive mechanoreceptors due to nerve endings with a highly sensitive capsular end to deformation, thus dynamically responding to deformation, but are insensitive to constant or stable changes. Ruffin termination results from multiple, thin capsule-tipped, and single axons and has slowly adapting mechanoreceptors and thus continues to receive information until a constant warning level is stimulated during deformation [17].
The tendons are surrounded by loose, porous connective tissue, which is called paratenon. A complex structure, paratenon, protects the tendon and allows shifting tendon cover format. Tendon sheaths consist of two continuous layers: parietal on the outside and visceral on the inside. The visceral layer is surrounded by synovial cells and produces synovial fluid. In some tendons, the tendon sheath extends along the tendon, while in others it is found only in the binding parts of the bone.
The parietal synovial layer is found only under the paratenon in the body regions where tendons are exposed to high friction. This is called the epitenon and surrounds the fascicles. In this case, epitenon’s synovial cells produce lubricating liquid. In regions where friction is less, tendon is surrounded by paratenon only. At the tendon-bone junction, the collagen fibers of endotenon continue into the bone and become a peritendon.
The regions of the tendon bonding to the bone consist of a dense connective tissue, which is able to adhere to the hard bone from the dense connective tissue and is resistant to movement and damage. Although they occupy a small area in size, the areas of adhesion to the bone have a complex structure that is much different from that of the tendon itself. According to the size of the load they carry, they show a different proportion of collagen bundles [18].
The tendons cling to the bone is a complex event; collagen fibers mix into fibrocartilage, mineralize, and then merge with the bone. “Sharpey’s penetrating fibers” continue with the external lamellar structure of the bone of tendon fibrosis along the period that is important for the entry of the tendon called enthesis. Sticking to the bone is done in two ways. In the first type, the adhesion of many collagen fibers is direct to the bone, while the second type indirectly adheres to the periosteum. In other words, the tendon is attached to the bone in the form of fibrous or indirect adhesion to the metaphysics and diaphysis of long bones or fibrocartilaginous or direct adhesion to the epiphyses of the bone. In fibrous adhesions, while the collagen fibers of the tendon are permanently adhered to the periosteum during bone development, fibrocartilaginous adhesions have a gradual transition from tendon to bone. This gradual transition in fibrocartilaginous adhesions includes the tendon, decalcified fibrocartilage, calcified fibrocartilage, and four zones of bone, so that the uniform distribution of the load at the adhesion site and the joint movement and the coordination of the collagen fibers are ensured. However, changes in the fibrocartilaginous structure due to compressive loading vary depending on the adhesion sites of the tendons. This ensures better protection against compressive forces. The bones of the tendons are composed of four regions within the bone; at the end of the tendon (region 1), collagen fibers enter the fibrocartilage (fibrous cartilage—region 2). As the fibrocartilage progresses, it becomes mineral fibrocartilage (area 3) and then integrates with cortical bone (fourth region). This transformation, which is more bone structure than tendon structure, leads to gradual increase of mechanical properties of the tissue [3, 19, 20, 21].
The tendons are mainly composed of three parts: the tendon itself, the muscle-tendon junction, and the bone insertion. In general, they pass through the joints and adhere to their distal. In this way, they increase the effectiveness of the muscles on the joints. At the same time, similar to bones, mechanical properties vary depending on the load carrying place. For this reason, knowing where they are helps us understand the structure. In fact, not every muscle has a tendon. While some tendons are involved in some muscles that play an active role in joint movements, the presence of some tendons is to increase muscle movement distances rather than the movement of the joint. For example, Achilles tendon is a very special tendon for the body carrying the loads by centralizing the strength of a few muscles. In contrast, some tendons, such as the posterior tibial tendon, act by distributing the load to several bones. Although it is known that most tendons originate from the muscle and adhere to the bone, some tendons may be the starting point for muscles, or two muscles are connected to each other through a tendon [22, 23].
The simplest classification for the tendons classified according to their shapes, settlements, and anatomical structures is the classification made according to their shapes. They can be very small and very long, and they can be very large and very short. Tendons are very variable according to their shape, long, round, rope-shaped (such as Achilles tendon), or short; flat tissue adhesion (such as bicipital aponeurosis) can be seen. In other words, tendons may change from flat to cylinder, from fan shape to ribbon shape. However, round tendons (such as flexor digitorum profundus) or flat tendons (such as rotator cuff, bicipital aponeurosis) are more involved in the body. In this simple classification, tendons are divided into round and flat and are very different from each other as structural and functional. For example, while round tendons respond equally to tensile loads with parallel collagen patterns, flat tendons such as rotator cuffs can respond microanatomically in the form of compression and shear forces due to longitudinal, oblique, and transverse collagen sequences. However, in round tendons, the section area is proportional to the maximum isometric strength of the muscle. In other words, due to parallel collagen sequences, flat tendons are resistant to compression and shear forces due to flat, longitudinal, and oblique collagen sequences in comparison to round tendons that respond equally to the tensils [3, 24].
Tendons can be classified in many ways according to their location, but the most logical one is the tendon classification in relation to the functions they see as the intraarticular (biceps long head and popliteus tendon) and the extraarticular (Achilles tendon). Most tendons are non-articular, but the intra-articular ones lack the ability to repair after injury as in the same intra-articular ligaments (an example of anterior cruciate ligament tear). At the same time, although most tendons adhere to the bone, some tendons form the origo point for the muscles (lumbrical muscles originate from the flexor digitorum profundus) or connect two muscles (such as omohyoid and digastric muscle). In addition, the large part of the tendon may originate from the muscle itself (gastrocnemius and soleus). For example, in some muscles tendons move into the muscle joint and tendon sticks at an angle. This allows a high proportion of muscle fibers to adhere to the tendon, thereby increasing the strength of the muscle-tendon unit but reducing the range of motion.
According to their anatomy, the tendons can also be classified as sheathed or synovial-coated (such as the long flexor of the fingers) or unsealed or paratenon-coated (such as Achilles tendon). In other words, these tendons, which are separated by intrasynovial and extrasynovial, have a higher slippage resistance compared to the intrasynovial tendon structure, when examined more closely. At the same time, the soft tissue protection and vascularity of these two tendons are different [20].
According to its functions, tendons can be classified as energy storage or positional tendons (Table 1). In general, the muscles tend to tendon to shorten the stress load; the affected tendon is stretched and the muscle can relax again when relaxed. This makes the tendon a structure that stores elastic voltage energy. The best example of energy storage tendons is Achilles tendon. Tibialis anterior tendons in human are examples of positional tendons, and they can never extend relatively. Positional tendons are rarely injured because they extend less [25, 26, 27].
Energy storage tendons | Positional tendons | |
---|---|---|
Function | -Storage and release of elastic stress energy | -Transport the forces created in muscles to the bones |
Material specifications | -Bimodal with smaller fiber diameter -More glycosaminoglycan and water content, softer matrix -Increased interfascicular slip due to lower intrafascicular rigidity | -Unimodal with a wider diameter of a fiber -Lower glycosaminoglycan and water content, the harder matrix -Tightly packed fascicles with less interfascicular slip at low loads |
Biomechanical features | -It can extend in physiological loads -Higher tensile strength -Lower tensile strength | -Cannot stretch in physiological loads -Lower tensile strength -Higher tensile strength |
Injury | -More | -Less |
Example | -Achilles tendon | -Anterior tibial tendon |
Classification and properties of tendons according to their functions.
In conclusion, tendons are composed of multiple bundles, fibroblast, and dense linear collagen fibrils, which form the macroscopic structure of tendons and give the fibrous appearance. The cell and matrix compositions of tendons are similar to ligaments and capsules and contain only small differences. In fact, they all have the same cell type and similar vascular and innervation sources. The extracellular matrix of tendons is largely composed of collagen fiber network and less proteoglycans, elastin, and other proteins. The main task of these components is to maintain the structure of the tendon and facilitate the biomechanical reaction of the tissue against mechanical loads.
Knowing where tendons are helps us understand the structure. While some tendons are involved in some muscles that play an active role in joint movements, the presence of some tendons is to increase muscle movement distances rather than the movement of the joint.
Prevalence of acute kidney injury (AKI) was evaluated at 22% in hospital settings in a large meta-analysis of 3.5 million patients and raised up to 57% when admitted to intensive care units (ICUs) [1, 2]. The incidence of dialysis-requiring AKI has increased by 10% yearly from 2000 to 2009 in the United States [3]. Hence, renal replacement therapy (RRT) is widely used in modern acute care settings as a supportive management of severe acute kidney injury (AKI) and multiorgan failure (MOF). While RRT in chronic end-stage kidney disease (ESRD) is mostly reserved for nephrologists, its prescription in context of acute-care settings is shared between many medical specialties.
The first section reviews the basic principles and characteristics of the different modalities used in ICUs nowadays. Then, the main section is meant to guide clinicians in evidence-based RRT prescribing by examining the most relevant body of literature published in the last decade. Indications, timing of initiation, modality choice, dosing, anticoagulation, and discontinuing RRT are discussed. Finally, some specific and more challenging scenarios are briefly covered as well as other pragmatic aspects.
Despite major improvements in technologies from the first experimental hemodialysis (HD) in 1924 to the first continuous arteriovenous hemofiltration (CAVH) circuit in 1977, general principles guiding the removal of water and solutes for almost any type of extracorporeal renal replacement therapies initiated in the ICU remain the same: diffusion, convection, ultrafiltration and sometimes adsorption (see Figure 1) [4]. These three major concepts will be integrated according to the renal replacement therapy (RRT) modality chosen. The notable exception is peritoneal dialysis (PD), which, nowadays, is rarely initiated in acute setting such as AKI in ICU adult populations. However, PD for AKI is often used in children and has been shown useful in resource-limited settings (e.g., no reliable access to electricity or CRRT devices) as well as in extraordinary circumstances when usual CRRT capacities have been overflowed (e.g., recent COVID19 pandemic). Nevertheless, in most centers, PD as a modality of RRT is restricted to ESRD patients requiring maintenance dialysis and is rarely an option in ICUs. For these reasons, only blood-based extracorporeal renal replacement therapies will be reviewed in this Chapter.
Principles guiding blood-based extracorporeal RRT.
All extra-corporeal RRT technologies used in ICUs can be separated into three modalities: intermittent hemodialysis (IHD), prolonged intermittent RRT (PIRRT) (also called sustained low-efficiency dialysis [SLED]), and continuous RRT (CRRT). Their ability in fluid and solute removal is all based on one or on the combination of the basic principles described above. (See Figure 2).
Schematic representation of IHD and CRRT circuits’ configuration. (A) HD: A dedicated intermittent HD device generates large volumes of physiological dialysate using sterile water and chemical concentrates. Up to 800 mL/min of new dialysate can be constantly generated for most HD devices. The composition/prescription of this dialysate can be individualized according to the patient’s need. (B)(C)(D) a dedicated CRRT machine uses commercially available bags of physiological solution, using low effluent flow (20–35 mL/kg/h).
In HD (A) and CVVHD (B), blood and dialysate circulate on each side of the semipermeable membrane. Diffusion is the driving force that contributes to solute clearance. For all RRT devices, pressure differential between the two compartments, using dedicated pumps to generate transmembrane pressure (TMP), controls convection flow and ultrafiltration rate. The removed liquid containing waste is usually called effluent for all modalities.
In CVVH (C), convection is the main mechanism used to provide solute clearance. The generation of ultrafiltrate is continuously compensated by the reinjection of replacement fluid. That replacement can be injected before the filter, after the filter, or a combination of both (called pre- vs. post-filter reinjection ratio). Adding pre-filter replacement fluid dilutes blood and its components, notably its hematocrit reducing the overall thrombogenicity. Hence, increasing pre-filter/post-filter ratio reduces the risk of circuit clotting. On the opposite, a proportional increase in hematocrit at the end of the filter will occur when increasing the convection volume in a 100% post-filter CVVH configuration.
CVVHDf (D) results from the combination of (B) and (C) where both convection and diffusion achieve solute clearance. The replacement fluid may be mixed pre- and post-filter as well in addition to using a countercurrent dialysate flow. However, diluting blood pre-filter also decreases the concentration gradient, which is a major driving force in diffusion. The prescription should be adapted according.
Net fluid balance (net UF) can be obtained in all modalities: in IHD and CVVHD, by generating a TMP, which leads to ultrafiltrate. In CVVH and CVVHDF, the volume of reinjection needs to be slightly lower than the ultrafiltrate generates, which leads to a negative fluid balance.
It should be noted that some centers can generate high volumes of convection when using intermittent RRT. This modality is named hemodiafiltration (HDF), requires an adapted dialysis machine, and is increasingly used in Europe and Asia for ESRD patients. However, its implementation in ICU settings remains limited, partly due to the need to maintain a water treatment system adapted to HDF [8]. As a result, when reporting intermittent RRT in the ICU, we generally consider only IHD.
From a clinical standpoint, each modality is associated with typical blood flow rates (Qb) and dialysate flow rates (Qd) which translates into conventional treatment durations and frequencies (see Table 1).
Intermittent hemodialysis (IHD) | Prolonged intermittent renal replacement therapy (PIRRT) | Continuous renal replacement therapy (CRRT) | |
---|---|---|---|
IHD: D HD | SLED: D SLED | CVVH: C CVVHD: D CVVHD | |
IHD machine | Usually, IHD machine | CRRT machine | |
3−4 hours | 6−12 hours | Continuous | |
3−4 days/week | 3–7 days/week | Continuous | |
350−400 | 150−250 | 100−250 | |
500−800 | 100−300 | 25−30 | |
0–5000 mL/session | 0–5000 mL/session | 0–200 mL/hour |
Typical prescribing patterns of RRT modalities.
IHD: intermittent hemodialysis, HDf: intermittent hemodiafiltration; SLED: sustained low-efficiency dialysis, SLEDf; sustained low-efficiency hemodiafiltration.
PIRRT represents the application of intermittent hemodialysis technology (machine, filter, dialysate) with a modification of the typical IHD prescription. The objective is to provide a better hemodynamic tolerability than IHD. Hence, in centers offering this modality, PIRRT is generally used in place of CRRT such as in patients with hemodynamic instability, especially if a substantial negative fluid balance (net UF rate) is desired. PIRRT is typically delivered 8 hours with slower blood and dialysate flows than IHD. However, this modality is not optimal for acute RRT indication such as severe hyperkalemia or intoxication with dialyzable substances (e.g., salicylates, methanol, and ethylene glycol) because of its lower flow rates. In some centers, a dedicated HD nursing staff is required to deliver a PIRRT treatment.
CRRT is characterized by small flow rates, notably reinjection, dialysis, and UF rates. It allows reducing the hemodynamic effects of fluid and solute changes. However, this continuous modality requires a permanent connection to the CRRT machine, supervision and is at high risk of clotting if no anticoagulation is prescribed. In most centers, an adequately trained ICU nurse can manage a CRRT treatment.
Even though RRT is widely used, and most ICUs have elaborated standardized protocols to simplify IHD/CRRT prescription, many factors need to be considered before, during, and when stopping this therapy: patient’s characteristics, local resources, physician’s preferences as well as scientific evidence.
Indications for initiating RRT in acute care are frequently classified as
|
Absolute indications of initiating RRT.
On the other hand, whether to initiate and when to do so while not meeting any of these indications has received a lot of interest in the last few years in the attempt to prevent morbidity and mortality. Indeed, initial observational studies had supported the rationale that a proactive/early RRT will help to quickly normalize renal homeostasis while minimizing inflammation and uremic toxicity. On the other hand, this approach could lead to initiate RRT in patients who will never develop clear indications as some will spontaneously recover in addition to exposing them to unnecessary RRT complications. This has led to the constantly evolving
Studies (year) | Settings | Population | Early-group criteria | Delayed-group criteria | Primary outcome | Secondary outcomes or safety endpoints |
---|---|---|---|---|---|---|
ELAIN (2016) | Germany single center CVVHDF (30 ml/kg/h) | n = 231 93.5% surgical (46.8%-cardiac) SOFA 15.6 vs. 16.0 | < 8 h of stage 2 RRT: 100% | < 12 h of stage 3 or K+ > 6 mmol/L, *urea >100 mg/dL, Mg2+ > 4 mmol/L, UO < 200 ml/12 h, refractory edema RRT: 91% | 90-day mortality: E: 39.3% D: 54.7% HR 0.66 (0.37–0.97, | Median RRT duration (days): E: 9 vs. D: 25 HR:0.69 (0.48–1.00) 90-day RRT requirement: OR 0.87 (0.31–2.44) |
AKIKI (2016) | France 31 ICUs 30% CRRT-only >50% intermittent | n = 620 80% sepsis-related SOFA 10.9 vs. 10.8 | < 6 h of stage 3 RRT: 98% | K+ > 6.0 mmol/L, urea>112 mg/dL, pH < 7.15, pulmonary edema or oliguria/anuria >72 h RRT: 51% | 60-day mortality: E: 48.5% D: 49.7% (p = 0.79) | 60-day RRT dependence: E: 2% vs. D: 5% (p = 0.12) CRBI: E: 10% vs. D:5% ( |
IDEAL-ICU (2018) | France 29 ICUs stopped early (futility) CRRT and IHD | n = 488 <48 h of septic shock SOFA 12.2 vs. 12.4 | < 12 h of Failure stage (RIFLE) RRT: 97% | K+ > 6.5 mmol/L, pH < 7.15, pulmonary edema or persistent AKI after 48 h RRT: 62% | 90-day mortality: E: 58% D: 54% (p = 0.38) | Median RRT duration (days): E: 4 vs. D: 2 90-day RRT dependence: E: 2% vs. D: 3% (p = 1.00) |
STARRT-AKI (2020) | 15 countries 168 ICUs 70% CRRT 30% intermittent | n = 3019 65% medical 35% surgical SOFA 11.6 vs. 11.8 | <12 h of stage ≥2 RRT: 97% | K+ > 6 mmol/L, pH < 7.2, HCO3− < 12, pulmonary edema or persistent AKI 72 h after inclusion RRT: 62% | 90-day mortality E: 43.9% D: 43.7% (p = 0.92) | Median RRT duration (days): E: 4 vs. D: 5 RR = −0.48 (−0.82−(−)0.14) 90-day RRT dependence: E: 10% vs. D: 6% RR = Any adverse event: E:23% vs. D:16.5% ( |
AKIKI-2 (2021) | France 39 ICUs 40% CRRT 60% intermittent | n = 278 55% septic shock For inclusion (3/3): 1)MV or vasopressor 2)AKI stage 3 3)Oligo-anuria >72 h or urea 112 to 140 mg/dL | <12 h of fulfilling inclusion criteria RRT: 98% | K+ > 6 mmol/L, pH < 7.15, *urea>140 mg/dL, pulmonary edema (No time criteria) RRT: 79% | RRT free days (day 28) E:12 D: 10 (p = 0.93) | 60-day mortality: E:44% vs. D:55% (p = 0.07) RRT duration (days) E:5 vs. D: 5 (p = 0.75) 60-day RRT dependence: E:4% vs. D: 1% (p = 0.62) |
Landmark RCTs on timing of RRT initiation.
Urea conversion to SI units: 100 mg/dL = 35.7 mmol/L, 112 mg/dL = 40 mmol/L, 140 mg/dL = 50 mmol/L.
E: Early-group, D: Delayed-group, UO: urine output, CRBI: Catheter-related bloodstream infection, MV: mechanical ventilation.
KDIGO (2012) [10] | RIFLE (2007) [11] | ||||
---|---|---|---|---|---|
1.5−1.9 x baseline Or ≥ ↑ 0.3 mg/dL | <0.5 ml/kg/h x 6−12 h | 1.5 x baseline Or ↓ GFR > 25% | <0.5 ml/kg/h x 6 h | ||
2.0−2.9 x baseline | <0.5 ml/kg/h x ≥ 12 h | 2 x baseline Or ↓ GFR > 50% | <0.5 ml/kg/h x 12 h | ||
≥ 3.0 x baseline Or ≥ 4.0 mg/dL Or Initiation of RRT | <0.3 ml/kg/h x ≥ 24 h Or Anuria ≥12 h | 3 x baseline Or ↓ GFR > 75% Or ≥ 4.0 mg/dL | <0.3 ml/kg/h x ≥ 24 h Or Anuria ≥12 h | ||
Persistent acute renal failure >4 weeks | |||||
ESKD >3 months |
KDIGO and RIFLE classifications of AKI.
↑: increase of serum creatinine, ↓: decrease of GFR, ESKD: end-stage kidney disease.
Creatinine conversion to SI units: 0.3 mg/dL = 26.8 μmol/L; 4.0 mg/dL = 353.6 μmol/L).
In 2016, the results of the first large RCT trying to answer this complex question were published. The Early Versus Late Initiation of Replacement Therapy In Critically Ill Patients with AKI (
In an attempt to definitively clarify the question of
STARRT-AKI has confirmed evidence against the preemptive use of RRT prior to developing standard RRT initiation criteria. However, a question remained unanswered: how far can we delay RRT initiation without negative outcomes? The Artificial Kidney Initiation in Kidney Injury-2 (
As shown in those studies where a substantial number of patients randomized to a delayed strategy never required RRT initiation, correctly predicting who will progress to an AKI stage where RRT is required is complex in a real-life setting. Since the last decade, a growing number of tools and biomarkers have been developed, and reported useful, to inform about the likelihood a patient with AKI will worsen, and progress to receive RRT [16]. Various urine and blood biomarkers have been studied, such as the urine neutrophil gelatinase-associated lipocalin (uNGAL), interleukin-18 (IL18), or the NephroCheck (TIMP2*IGFBP7), with a pooled AUC or 0.720, 0.668 and 0.857 respectively. More functional biomarkers, such as a diuretic response of less than 200 mL to a loading dose of 1.0 to 1.5 mg/kg of intravenous furosemide (FST – Furosemide stress test) have also been shown useful in predicting the risk of progression to RRT with a pooled sensitivity and specificity of respectively 0.84 (95% CI 0.72–0.91) and 0.77 (95% CI 0.64–0.87) [17]. The growing interest in such complementary tools is associated with the publication of multiple confirmation studies in recent years, leading to recent consensus in favor of their use in standard clinical practice [18]. However, their implementations in real-life ICU settings are still in the beginning.
In summary, only the first smallest single-center RCT of almost entirely surgical patients has shown a mortality benefit of early initiation of RRT compared to a delayed strategy. The three subsequent trials consisting of more than four thousand patients with a variety of modalities and populations (including surgical subgroup analysis) concluded the absence of such advantages of early initiation. Also, the added resources required to initiate 35–45% more RRT must not be neglected. Furthermore, significant harms have been reported in the early-initiation approach: catheter-related bloodstream infections (AKIKI), 90-day RRT dependence, and any adverse event (STARRT-AKI). On the other hand, the latest trial might help in determining the upper limit of postponing RRT. Therefore, a conservative approach consisting of watchful waiting, unless a life-threatening indication emerges, seems recommended for most cases with the caveats that the risk-benefits ratio is uncertain once criteria used for inclusion in the latest trial are reached.
Although there are substantial variations in practice, hemodynamic instability is the most common reason to choose slow intermittent (PIRRT) or continuous (CRRT) therapy. The 2012 KDIGO AKI guidelines suggest using CRRT rather than intermittent RRT for these patients (grade B – moderate quality of evidence) [19]. However, empirical data has not proven what might seems obvious at first to clinicians. In fact, the use of PIRRT or CRRT compared to IHD in randomized trials has failed to demonstrate differences in hard outcomes such as mortality or recovery of renal function [20, 21, 22, 23, 24, 25, 26] (see Table 5). Still, it is important to note that heterogeneity is found in dosing, CRRT subtypes, delivered blood flow, and that the most unstable patients were excluded for most of them.
Study (year) | Design | # of Pts | CRRT | IHD | Survival | Renal Recovery |
---|---|---|---|---|---|---|
Mehta et al. (2001) | RCT | 166 | CVVHDF or CAVHDF | Qb 200–300 | CRRT 34.5% IHD 52.4% | CRRT 34.9% IHD 33.3% (p = NS)* |
Guerin et al. (2002) | Prospective observational (unadjusted) | 587 | variable | variable | CRRT 20.6% IHD 41.2% | Not mentioned |
Gasparovic et al. (2003) | RCT | 104 | CVVH | Qb 200–250 | CRRT 28.8% IHD 40.4% (p = NS) | Not mentioned |
Augustine et al. (2004) | RCT | 80 | CVVHD | Qb 300 | CRRT 32.5% IHD 30.0% (P=NS) | CRRT 12.5% IHD 10.0% (p = NS)* |
Vinsonneau et al. (2006) | RCT | 259 | CVVHDF | Qb 278 | CRRT 32.6% IHD 31.5% (p = 0.98) | CRRT 93.3% IHD 90.2% (p = NS)** |
Lins et al. (2009) | RCT | 316 | CVVH | Qb 100–300 | CRRT 41.9% IHD 37.5% (p = 0.430) | CRRT 74.5% IHD 83.1% (p = 0.474)** |
Schefold et al. (2014) | RCT | 252 | CVVH | Qb 200–250 | CRRT 45.4% IHD 39.7% (p = 0.72) | CRRT 77.2% IHD 73.6% (p = 0.90)** |
Truche et al. (2016) | Prospective observational (adjusted) | 1360 | CVVH or CVVHD | variable | CRRT 53.5% IHD 65% (p = NS) | CRRT 64.7% IHD 42.9% (p = 0.29)** |
Major studies comparing CRRT to IHD.
In all patients randomized.
In patients who survived at ICU discharge.
CAVHDF: Continuous arteriovenous hemodiafiltration, p: p-value, NS: Non-significant.
As mentioned earlier, in patients with hemodynamic instability, the choice between PIRRT and CRRT mostly depends on local availability. The level of evidence regarding PIRRT is still limited, but advantages compared to CRRT may include: reduced costs and flexible treatment schedule allowing the patient to be more easily mobilized during daytime. As opposed to fixed CRRT solutions, the dialysate composition can be more easily adapted to the patient’s needs even during the dialysis session. However, no clear antimicrobial dose adjustments are recommended with that modality. In patients who regain stability, the RRT prescription can be rapidly adapted, from PIRRT to a conventional IHD prescription, using the same technology.
Given that both clearance methods are efficient at clearing small solutes, the question is mainly about the added benefit (or harm) of removing medium-sized pro-inflammatory molecules such as cytokines, endotoxins, or exotoxins. In ESRD patients, for those treated with HDF compared to IHD, some benefits were demonstrated in large RCTs on reducing intradialytic hypotension and use of erythropoietin-stimulating agents, but more importantly, an all-cause mortality benefit (HR 0.78, 95%CI 0.62–0.98) and cardiovascular mortality (HR0.69, 95%CI 0.47–1.0) were obtained when optimal convective volumes were delivered [27]. However, in AKI no such benefits have been demonstrated with certainty. A 2012 meta-analysis of 19 RCTs, comparing hemofiltration (CVVH) to hemodialysis (mostly CVVHD) found no effect on mortality (RR 0.96, 95%CI 0.71–1.15), or other clinical outcomes (RRT dependence in survivors, vasopressor use, organ dysfunction) despite increased clearance of medium to larger molecules, including inflammatory cytokines [28]. Despite fewer studies, similar results have been shown when comparing intermittent modalities offering diffusion only (IHD) to convection (HDF) in ICUs [8].
Since neither the modality mode (
Modality | Anticoagulation* | ||
---|---|---|---|
IHD | Flow | High (Qb < Qd) | Without ± saline flush ± heparin-coated filters Systemic: UFH (continuous) LMWH (bolus) |
Short sessions – Allow exams and mobilization Lowest cost Lowest immobilization | |||
Hypotension with rapid fluid removal Higher complexity (dedicated dialysis staff) | |||
HDF -Removal of medium-sized molecules (added benefit uncertain in AKI) -Large amount of replacement fluid requiring ultra-pure water (Dedicated water treatment complicating ICU implementation) | |||
CRRT | Flow | Low Qd and convection, Moderate Qb | Without Systemic: UFH Regional: citrate |
Hemodynamic stability No treatment-induced increase intracranial pressure Fine fluid control Lower complexity to operate (ICU staff only) | |||
Hypothermia – Negative energetic balance Immobilization Higher costs (commercial bag for replacement fluids) | |||
PIRRT | Flow | moderate (Qb ≥ Qd) | Without ± saline flush ± heparin-coated filters Systemic: UFH, LMWH |
Online production of dialysate and IHD tubing (lower cost than CRRT) Reduced immobilization (low rehabilitation impact if done overnight) | |||
Higher complexity (dedicated dialysis staff in some centers) |
Pragmatical considerations with RRT modalities.
See anticoagulation section for more details.
Qb: blood flow rate, Qd: dialysis flow rate, UFH: unfractionated heparin, LMWH: Low-molecular-weight heparin.
Like any treatment, RRT intensity or delivered dose must be tailored to the patient’s need. While underdosing may result in insufficient clearance of uremic toxins, uncontrolled electrolytes, or acid–base status, overdosing leads to electrolytes disorders, hydrophilic micronutrients depletion, hazardous therapeutics dosing (e.g., antibiotics), and unnecessary expenses [29]. Ultrafiltration is a critical component of RRT prescribing but is not part of
For all intermittent modalities, as seen in Table 7, the blood flow rate is the limiting factor highlighting the value of maximizing the potency of vascular access. A subsequent option to optimize clearance is increasing the
Studies (year) | Settings | Strategy | Dose delivered (Kt/V or total effluent rate ± SD) | Mortality | Secondary outcomes or safety endpoints |
---|---|---|---|---|---|
ATN (2008) | USA 27 ICUs n = 1124 AKI due to ATN | 60-day mortality: L: 51.5% I: 53.6% (p = 0.47) | Hypotension requiring vasopressor L: 10% vs. I: 14% (p = 0.02) Electrolyte disturbance L:20.7% vs. I:25.6% (p = 0.05) | ||
IHD/SLED 3x/week | 1.31 ± 0.33 | ||||
CVVHDF 20 mL/kg/h | 22.0 ± 6.1 | ||||
IHD/SLED 6x/week | 1.32 ± 0.36 | ||||
CVVHDF 35 ml/kg/h | 35.8 ± 6.4 | ||||
RENAL (2009) | Australia & New Zealand 35 ICUs n = 1508 AKI | 90-day mortality: L: 44.7% I: 44.7% (p = 0.99) | Hypophosphatemia L: 54% vs. I: 65% | ||
CVVHDF 25 mL/kg/h | 22.7 ± 17.8 | ||||
CVVHDF 40 mL/kg/h | 33.4 ± 12.8 |
Landmark RCTs on RRT dosing strategy.
AKI: acute kidney injury; ATN: acute tubular necrosis; L: Less-intensive group, I: Intensive group.
One RCT includes intermittent modalities compared to dosing-based strategies. The Acute Renal Failure Trial Network
For CRRT, as the trans-membrane equilibrium is almost achieved at the end of the filter for small solutes, the limiting factor for clearance is therefore the effluent flow rate. Hence, the total delivered effluent rate, normalized to actual weight, is used to quantify clearance. According to the circuit configuration, that total effluent rate corresponds to the sum of the reinjection flow (pre- and post-filter) (if CVVH or CVVHDF) + the rate of dialysate flow (CVVHD or CVVHDF) + UF (see Figure 3). Even if the UF rate is included in the equation of the delivered dose, in clinical practice it is added once the targeted dose has been prescribed. First, it usually represents a fraction of total effluent in an average size patient.6 Also, since this rate is regularly modified, its exclusion always allows minimally sufficient delivered dose. Other options to optimize CRRT clearance such as increasing blood flow rate or filter surface have a reduced effect on optimizing clearance efficiency.
Example of CRRT dosing using a CVVHDF circuit.
Between 2000 and 2008, four major RCTs evaluated the impact of different CRRT doses in critically ill patients. In 2000, using CVVH in 425 patients, three groups were compared [20 vs. 35 vs. 45 (mL/kg/h)] and mortality was significantly higher in the lowest UF rate group at 15 days after stopping RRT [35]. No difference was reported between the two higher rates. In 2002, using CVVH in 106 patients, three groups were compared [early high-volume (48.2 mL/kg/h) vs. early low-volume (20.1 mL/kg/h) vs. late low-volume (19.0 mL/kg/h)] and no mortality benefits was seen at 28 days [36]. In 2006, a study of 206 patients compared two groups [CVVH (25 mL/kg/h) vs. CVVHDF (reinjection rate 25 mL/kg/h + dialysis rate 18 mL/kg/h)] and mortality was significantly higher in the CVVH-only (at 28-day and three months) [37]. In 2008, using CVVHDF in 254 patients [20 vs. 35 (mL/kg/h)] and no mortality benefit was detected [38].
To confirm these previous findings from single-center trials, two multicenter RCTs (USA and AUSNZ) focused on this topic (see Table 7). In 2008, the
In summary, for both modalities, current evidence does not support using intensive therapy for all patients. For intermittent modalities, it seems appropriate to prescribe IHD at least 3 times a week to maintain volume and metabolic balance as long as there is no sign of underdosing (either a Kt/Vurea < 1.2 per session or URR < 67%). The weekly Kt/vurea does not apply in patients requiring additional IHD sessions to achieve a volume balance, as well as in patients with significant renal function. For continuous therapies, a prescribed effluent volume of 25–30 mL/kg/h is adequate in most scenarios to ensure a delivered dose of at least 20–25 mL/kg/h.
Sustained circuit patency is crucial to optimize delivered RRT and contact of blood with extracorporeal circuit activates platelets and pathways of coagulation [40]. KDIGO-AKI guidelines suggest a flow chart to guide anticoagulation decision [19]. At first, it integrates the risk–benefit ratio of anticoagulation and whether another condition requiring systemic anticoagulation is present. RRT can be performed without or with systemic or regional anticoagulation.
Although KDIGO-AKI guideline recommends using anticoagulation when bleeding risk is low, it is still common practice in many centers to deliver RRT without anticoagulation in this scenario unless filter patency is an issue. For example, in the STARRT-AKI trial, 24% of the 3019 included patients had no anticoagulation at the initiation. A key concept in preventing circuit clotting is maintaining a low filtration fraction (FF). Filtration fraction indicates relative fluid removed from blood across the dialysis membrane. Higher percentage means higher concentration of blood constituents. Fractions above >20% are associated with increased clotting [41]. The equation for CRRT (blood flow rate being converted from mL/min to mL/h to standardize units) is:
Modifying elements only found to either the numerator or the denominator (marked in bold) have higher impact on the FF. Hence, from a clinical perspective, reducing FF is achievable by modifying flow rates: reduce net UF, increase pre-filter/post-filter ratio, increase blood flow, reduce hematocrit. Additionally, since hematocrit might be reduced by pre-filter reinjection, it is obvious that administering blood transfusion directly pre-filter should be avoided when possible. Also, the catheter patency is essential by allowing prescribed flow rates, by avoiding stasis induced by alarms (e.g., kinked) and by maintaining a laminar flow (right jugular or femoral access).
For intermittent therapies, major assets helping prevent clotting are shorter sessions and higher blood flows, but clotting may be seen even if using heparin-coated filters, especially when substantial UF volume is removed. If convection is used (HDF or SLEDf), pre-filter reinjection can be used as well.
Most used agents are unfractionated heparin (UFH) and low-molecular-weight heparins (LMWH). Mostly reserved for patients with heparin-induced thrombocytopenia (HIT), direct thrombin inhibitors (e.g., argatroban and bivalirudin) or Xa inhibitors (e.g., fondaparinux and danaparoid) have been used in intermittent and continuous therapies, but will not be discussed further [42, 43].
UFH has some advantages (e.g., short half-life, antagonist readily available, low costs, and a large experience), but has substantial drawbacks (e.g., narrow therapeutic, unpredictable kinetics and heparin resistance, HIT) [19]. Thrombocytopenia is frequently encountered in ICU occurring in up to 44% of patients. However, HIT remains relatively uncommon in critically ill patients, with a reported incidence from 0.2–5% [44], and has been reported with intermittent and continuous RRT. When used solely for circuit anticoagulation, both the loading and infusion UFH doses need to be adapted to the patient’s bleeding/clotting risk as well as continuously monitored with aPTT.
LMWH has replaced UFH in most dialysis units (intermittent therapies) mainly because of convenience of a single dose at start of session associated with the same efficacy (at preventing circuit thrombosis) and security (bleeding). [45]. In addition, a more reliable response is obtained (no monitoring required) along with a reduced risk of HIT. LMWH has been used for CRRT with monitoring of anti-Xa levels [46], but longer half-life and risk of accumulation combined with incomplete reversal by protamine may limit widespread use.
When systemic anticoagulation is not warranted by another indication than maintaining RRT circuit, regional anticoagulation is the recommended strategy. Regional heparinization has been described in CRRT (combining pre-filter UFH, and post-filter protamine), but KDIGO recommends against its use, notably in patients with increased bleeding risk [19]. Likewise, use of regional citrate anticoagulation (RCA) has been evaluated in intermittent therapies [47] but is not common practice. Hence, emphasis will be placed on RCA in CRRT.
As demonstrated in Figure 4, RCA may be perceived as complex [48] but has undeniable advantages: no risk of HIT, lower risk of bleeding compared to UFH along with longer filter lifespan. It is therefore recommended as first line for anticoagulation in CRRT in KDIGO-AKI guideline if no contraindication [19]. A 2015 meta-analysis demonstrated reduced circuit loss compared to UFH [HR 0.76 (95%CI 0.50–0.98) for systemic and HR 0.52 (95%CI 0.35–0.77) for regional] and reduced bleeding [RR 0.36 (95%CI 0.21–0.60)]. [49]. A 2020 German RCT of 638 patients in 26 centers demonstrated longer filter lifespan (47 vs. 26 hours, p < 0.001), no mortality difference (51.2% vs. 53.6%, p = 0.38), fewer bleeding complications (5.1% vs. 16.9%, p < 0.001), but more infections (68% vs. 55.4%, p = 0.002) in RCA compared to systemic heparin [50].
CVVHDF with regional citrate anticoagulation (RCA). 1) blood, citrate solution, and optional calcium-free replacement fluid mix pre-filter. 2) citrate chelates circulating calcium (required for intrinsic and common pathways of coagulation). 3) calcium-free dialysate (avoiding calcium diffusion from dialysate to blood compartment) circulates countercurrent. 4) replacement fluid and calcium infusion to normalize calcemia are reinjected post-filter.
Thorough protocols and expertise in preventing/monitoring complications are required during RCA. The most immediate risk being unreplaced calcium since most complex (Ca-Citrate) is removed by the filter and may lead to severe hypocalcemia. So, one must be extremely careful if the calcium replacement IV line is assembled independently (e.g., CRRT machine continues, but calcium IV line is no longer potent). Citrate metabolism is the next consideration. The liver metabolizes one citrate into three bicarbonates. Even though low bicarbonate replacement and/or dialysate fluids are usually used, RCA is associated with more metabolic alkalosis than heparin [50]. If the liver cannot metabolize citrate, accumulation can be seen and translate in an anion gap metabolic acidosis associated with rise in total calcium levels, but decline ionized calcium. Thus, monitoring total calcium/ionized calcium ratio is helpful and a ratio > 2.5 is a sign of citrate accumulation which is also associated with hypernatremia and hypomagnesemia. Of note, once believed an absolute contraindication of RCA, it has been used safely in patients with liver diseases. A 2019 meta-analysis of 10 observational studies (1241 patients with liver dysfunction) showed no difference in pH, bicarbonate, metabolic alkalosis, lactate levels and total/ionized calcium ratios compared to patients without liver disease [51]. However, a more careful approach than in usual patients should be taken (e.g., tighter biochemical monitoring, lower citrate dose or lower total calcium/ionized calcium threshold) to regularly reassess its safety.
In summary, sustained circuit patency is required to optimize RRT. Understanding filtration fraction is of great help, mainly if anticoagulation is contraindicated. Otherwise, if no other indication mandates systemic anticoagulation, LMWH is the usual first choice for intermittent therapies and RCA for CRRT.
Literature is lacking to guide discontinuation of RRT initiated in context of AKI as revealed by the KDIGO-AKI recommendation that simply states “when it is no longer required, because kidney function has recovered to meet patient need or because RRT is no longer consistent with goals of care” [19]. Assessment of recovering kidney function in particularly difficult during RRT. While on intermittent therapy, steady state is not attained therefore excluding use of routine clearance measurements. Interdialytic evaluation of urine volume and creatinine, absolute rise of serum biomarkers (creatinine and BUN), but most probably the rising kinetic over time are frequently used. In a prospective observational study, spontaneous urine output was the best predictor of weaning RRT [52]. A recent systematic review found that urine output prior to RRT discontinuation was the most studied variable, but no threshold value could be determined due to heterogeneity of studies [53]. Pooled analysis found a sensitivity of 66% and specificity of 74% to predict RRT discontinuation, but cut-off values varied from 100 mL increase/day to >1720 mL/24 h. Of note, in one RCT, diuretic-induced diuresis had no benefit on repeated need for RRT or renal recovery [54]. In a retrospective study, a 24-hr urine creatinine clearance >15 ml/min was associated with absence of CRRT need at 14 days [55]. In another study, a 24 h urine creatinine of ≥5.2 mmol on day 2 post-RRT had a 86% sensitivity and 81% specificity of not requiring additional RRT treatment [56]. On the other hand, longer duration of RRT, more severe disease (SOFA score) and older age were associated with restarting RRT which correlated with higher mortality [57].
In summary, clear guidance in stopping RRT is lacking and implies at first a minimal diuresis to avoid marked net fluid accumulation. Then, careful monitoring of clinical (weight, volume balance, diuresis) and paraclinical (serum biomarkers, urine creatinine clearance) data are valuable tools.
Most of the content discussed in previous sections refers to general considerations for understanding and prescribing competently RRT in ICU. However, some challenging situations encountered in clinical practice and pragmatic concerns will be briefly reviewed.
Mild to moderate dysnatremias are frequent in critically ill patients, especially at initial presentation. Maximum correction rate and approach to treatment differ between guidelines [58]. Though, consensus exists that inadequate correction of chronic severe hyponatremias (<125 mmol/L for >48 hours) should be avoided due to risk of developing osmotic demyelination syndrome (ODS) [59]. Concurrent urgent need for RRT and this condition can be particularly challenging. Since most IHD machines have a minimum sodium of 130 mmol/L, even by prescribing short duration, low blood and dialysate flow rates, overcorrection is a possibility. In the opposite, CRRT has been used effectively at correcting hyponatremias in a predictable manner either by adding a 5% dextrose pre-filter infusion or via customized hypoosmolar dialysate fluids [60].
Limited evidence exists about hypernatremia. Most IHD machines have maximum sodium of 160 mmol/L and CRRT correction protocol has also been published.
Published protocols for
Rosner and Connor [61] – PMID: 29463598, DOI: 10.2215/CJN.13281117
Yessayan, Yee [62] – PMID: 2479235, DOI: 10.1053/j.ajkd.2014.01.451
Published protocols for
Paquette, Goupil [63] – PMID: 27478592, DOI: 10.1093/ckj/sfw036
Patients suffering from acute liver failure (ALF) and acute severe neurologic injury are associated with cerebral edema and increased intracranial pressure. Rapid clearance of plasma solutes/toxins, as in intermittent therapy, can also lead to intracranial pressure (probably by water shift from sudden plasma hypoosmolality) [64].
In ALF, both the KDIGO-AKI and European Associated for Study of Liver (EASL) guidelines recommend CRRT instead of IHD in patients with ALF [19, 65]. Furthermore, RRT may be initiated before usual thresholds since it has been associated with increased transplantation-free survival, probably by clearance of ammonia as hyperammonemia is associated with increased intracranial pressure [66, 67]. Some published protocols used very high doses of CVVHDF (effluent 90 mL/kg/h) [68]. Also, targeting mild hypernatremias (145–150 mmol/L) is recommended in high-risk patients (acute renal failure, ammonia >150 μmol/L, grade IV encephalopathy and use of vasopressor) [65]. Options are customized reinjection and dialysis fluids as discussed above or by adding hypertonic saline perfusion.
Vascular access should deliver stable and sufficient blood flow. In acute care setting, temporary dual-lumen central venous access is used for most patients. Ultrasound-guided catheter insertion is associated with higher successful placement, reduced attempts and time of procedure with less complications [69]. Choosing the site might have short-, mid- and long-term consequences.
Higher rates of catheter dysfunction are observed with femoral and left jugular site compared to right jugular, but no significant difference of urea reduction ratio or RRT downtime was observed [70]. More pneumothoraxes are observed with subclavian access [71].
Risks of catheter-related bloodstream infections and symptomatic deep-vein thrombosis are higher in femoral than subclavian and similar between jugular and femoral [71].
In patient with considerable risk of RRT dependence (mainly with pre-existing advanced CKD), large-bore venous subclavian catheter should be avoided since it can compromise future ipsilateral vascular access due to stenosis.
Dialysis disequilibrium syndrome is a rare, potentially fatal but usually preventable complication of RRT. The pathophysiology is still debated but commonly reports an intracranial osmotic gradient due the rapid removal of urea and osmotic solute by RRT, leading to cerebral edema [72]. The large variation of symptoms and severity, from mild nausea to fatal cerebral herniation makes the diagnosis challenging. The syndrome is mostly reported in ESRD patients with advanced uremia who are initially started on high efficiency/ standard IHD prescription. Patients with ESRD (or with unknown kidney failure duration) should be treated with an adapted low-efficiency IHD prescription, for the first treatments, in order to minimize osmotic shift and risk of disequilibrium syndrome. A progressive increase in dialysate and blood flows and duration can therefore be implemented for the following treatments. Occurrence of this syndrome has also been reported in frail patients with septic shock and AKI even after repeated IHD sessions [73]. In patients who develop symptoms compatible to a disequilibrium syndrome during or quickly after an IHD session, management should include rapid treatment cessation and the administration of osmotic agents (mannitol, hypertonic saline) to quickly raise osmolality, despite the paucity of evidence. However, prevention should still be privileged. The overall risk of dialysis disequilibrium syndrome is lower with PIRRT, and notably reduced in patients treated with CRRT with standard dosing.
Intradialytic hypotension is a common complication and can cause further ischemic injury to the recovering kidneys, thereby reducing the probability of renal recovery. Obligate intake in critically ill patients can be high due to nutritional needs and intravenous fluids, which leads to large net UF especially if IHD is performed thrice weekly [74].
While patients in shock or with significant instability should be treated with PIRRT or CRRT (according to local availability), various interventions are associated with reduced risk of intradialytic hypotension during IHD (see Table 8). For most of them, despite being widely used in clinical practice, there is still a low level of evidence in context of AKI, as most evidence come from the ESRD population.
Minimizing UF |
|
Dialysis prescription |
|
Pharmacologic interventions |
|
Interventions to minimize intradialytic hypotension.
Renal replacement therapies delivered in ICUs are based on one or a combination of the same three basic principles of all extracorporeal blood-based treatments: diffusion, ultrafiltration and convection. Extensive literature has been published to guide clinicians for timing initiation, modality choice and dosing that could be summarized as:
Timing: For most cases, a conservative approach of watchful waiting is recommended. Accelerated strategies have been associated with added resources, higher infections and RRT dependence without substantial benefits.
Modality: Neither intermittent vs. continuous nor diffusion vs. convection have shown clear superiority. Hence, pragmatical considerations and mostly local expertise guide selection.
Dosing: For intermittent therapy, ensuring volume balance, metabolic homeostasis and a delivered Kt/V ≥ 1.2/session or URR ≥ 67% seems adequate. For CRRT, prescribing an effluent volume of 25–30 mL/kg/h to ensure a 20-25 mL/kg/h delivered is recommended in most scenarios.
Significant differences are observed between guidelines and clinical practice regarding anticoagulation and timing of initiation. Forthcoming guidelines updates will further help to standardize approach in RRT prescription. However, data are scarce to guide termination of RRT; large prospective trials are needed before strong recommendations could be made. Finally, usual prescriptions could not be adequate for some patients with challenging scenarios, where an individualized strategies need to be applied.
All figures have been created by the authors using BioRender.com. IntechOpen Ltd. can use and share these figures without additional permission.
The authors declare no conflict of interest.
All publications on this website are published under the Open Access model, without any subscription, registration, or access fees required from the user or his/her institution. In accordance with the Budapest Open Access Initiative's (BOAI) definition of Open Access, users are allowed to read, download, copy, distribute, print, search, and link to the full text versions of all Chapters. To read more about our Open Access Statement click here.
\n\nFor Editorial Policies for journals please consult individual journal pages.
',metaTitle:"Editorial policies",metaDescription:"Editorial policies",metaKeywords:null,canonicalURL:"/page/editorial-policies",contentRaw:'[{"type":"htmlEditorComponent","content":"All published Book Chapters are licensed under a Creative Commons Attribution 3.0 Unported License. Monographs are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others. Our Copyright Policy aims to guarantee that original material is published while at the same time giving significant freedom to our Authors. IntechOpen upholds a flexible Copyright Policy meaning that there is no copyright transfer to the publisher and Authors hold exclusive copyright to their work.
\\n\\n\\n\\nWith the purpose of protecting our Authors' copyright and the transparent reuse of Open Access content, IntechOpen has developed an Attribution Policy for works published under Creative Commons licenses.
\\n\\n\\n\\nIntechOpen is committed to disseminating high-quality scientific research in a manner that exemplifies the best practice in scholarly publishing. IntechOpen is an official member of the Committee on Publication Ethics (COPE), which advocates the maintenance of the highest ethical standards for all parties involved in the act of publishing, including Authors, Academic Editors of the book, Peer Reviewers, the publisher and Societies, where applicable.
\\n\\nIn line with publication ethics practices recommended by COPE, ICMJE, and other similar organizations, IntechOpen's contributing Authors, Academic Editors, and Peer Reviewers are required to declare fully all possible conflicts of interest.
\\n\\n\\n\\nIntechOpen's Authorship Policy is based on ICMJE criteria for authorship. In order to be identified as an Author, the following requirements must be met:
\\n\\nAll scientific works are subject to Peer Review prior to publishing. IntechOpen is a member of the Committee on Publication Ethics (COPE) and all participating referees and Academic Editors are expected to review submitted scientific works in line with the COPE Ethical Guidelines for Peer Reviewers where applicable.
\\n\\n\\n\\nThe Internet has changed the dynamics of scholarly communication and publishing which is why we find it necessary to clearly indicate our stance on what we consider to be a published scientific work. A significant number of working papers, early drafts, and similar works in progress are shared openly online between members of the scientific community. It has become common practice for researchers to announce their work on a personal website or a blog in order to gather comments and suggestions from other researchers. Such works and online postings are ‘published’ in the sense that they are made publicly available, but this does not mean that if submitted for publication by IntechOpen they are not original works. We differentiate between reviewed and non-reviewed works when determining whether a work is original and has been published in a scholarly sense or not.
\\n\\n\\n\\nTo identify instances of fraud and misconduct during the publishing process, IntechOpen implements a robust policy governing such occurrences. In line with our general commitment to openness, and in order to maintain the highest scientific standards, we are committed to transparency about our editorial policy regarding retractions and corrections.
\\n\\n\\n\\nWhen faced with potential misconduct, IntechOpen accepts its responsibility to maintain the integrity of the academic record. For particularly complex cases, IntechOpen might ask for the assistance of formal industry bodies or seek advice from an appropriate team of advisors.
\\n\\nIntechOpen's advisors are professionals and scholars with broad knowledge and understanding of different aspects of the scientific publishing process: editorial, authorship, and reviewing roles; publication ethics, copyright, and general legal issues; as well as bibliographic and technical standards.
\\n\\nIn order to provide us with unbiased insights, without compromising the privacy of third parties, IntechOpen presents problematic cases to its advisors in an anonymized format.
\\n\\nIntechOpen publishes books in the English language. If you are interested in the translation of Book Chapters, please check IntechOpen's Translation Policy.
\\n\\n\\n\\nIn line with the Principles of Transparency and Best Practice in Scholarly Publishing, you can access a more detailed description of IntechOpen's Advertising Policy.
\\n\\n\\n\\nAt IntechOpen we realize that exceptional circumstances can occur, resulting in a request for a refund. We will honor all justified requests in the specific instances outlined in our Refund Policy.
\\n\\n\\n\\nAll chapters will be published via IntechOpen's 'Online First' service meaning chapters will be published individually, immediately after review and before the entire book is ready for publication, allowing content to be shared, searched and cited straightaway, thereby generating early stage interest and momentum for your research
\\n\\nOnline First Chapters are considered published on the day they are posted and are citable from that date.
\\n\\nChapters will remain listed as Online First until the final versions of the books are published online. Following publication of the full monograph, Chapters will be redirected from the Online First version and will be available only through the final link of the official published page.
\\n\\nYou are invited to download, use, reproduce, make derivative works of, display, distribute and cite the Online First works. You can find "How to Cite and Reference" by following the link at the end of each online book chapter. Please be aware that it is possible that further editing and changes might be made before the final release of the book.
\\n\\nIf there are supplemental materials to the chapter, these will be published at the time the final book is published online.
\\n\\nReaders and Authors can notify us if they find any errors in the works published under Online First. All major errors will be accompanied by a separate correction notice, erratum or corrigendum (Retraction and Correction Policy.)
\\n\\nIntechOpen books are available online by accessing all published content on a chapter level.
\\n\\n\\n\\nIntechOpen publishes different types of publications.
\\n\\n\\n\\n\\n"}]'},components:[{type:"htmlEditorComponent",content:'
All published Book Chapters are licensed under a Creative Commons Attribution 3.0 Unported License. Monographs are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others. Our Copyright Policy aims to guarantee that original material is published while at the same time giving significant freedom to our Authors. IntechOpen upholds a flexible Copyright Policy meaning that there is no copyright transfer to the publisher and Authors hold exclusive copyright to their work.
\n\n\n\nWith the purpose of protecting our Authors' copyright and the transparent reuse of Open Access content, IntechOpen has developed an Attribution Policy for works published under Creative Commons licenses.
\n\n\n\nIntechOpen is committed to disseminating high-quality scientific research in a manner that exemplifies the best practice in scholarly publishing. IntechOpen is an official member of the Committee on Publication Ethics (COPE), which advocates the maintenance of the highest ethical standards for all parties involved in the act of publishing, including Authors, Academic Editors of the book, Peer Reviewers, the publisher and Societies, where applicable.
\n\nIn line with publication ethics practices recommended by COPE, ICMJE, and other similar organizations, IntechOpen's contributing Authors, Academic Editors, and Peer Reviewers are required to declare fully all possible conflicts of interest.
\n\n\n\nIntechOpen's Authorship Policy is based on ICMJE criteria for authorship. In order to be identified as an Author, the following requirements must be met:
\n\nAll scientific works are subject to Peer Review prior to publishing. IntechOpen is a member of the Committee on Publication Ethics (COPE) and all participating referees and Academic Editors are expected to review submitted scientific works in line with the COPE Ethical Guidelines for Peer Reviewers where applicable.
\n\n\n\nThe Internet has changed the dynamics of scholarly communication and publishing which is why we find it necessary to clearly indicate our stance on what we consider to be a published scientific work. A significant number of working papers, early drafts, and similar works in progress are shared openly online between members of the scientific community. It has become common practice for researchers to announce their work on a personal website or a blog in order to gather comments and suggestions from other researchers. Such works and online postings are ‘published’ in the sense that they are made publicly available, but this does not mean that if submitted for publication by IntechOpen they are not original works. We differentiate between reviewed and non-reviewed works when determining whether a work is original and has been published in a scholarly sense or not.
\n\n\n\nTo identify instances of fraud and misconduct during the publishing process, IntechOpen implements a robust policy governing such occurrences. In line with our general commitment to openness, and in order to maintain the highest scientific standards, we are committed to transparency about our editorial policy regarding retractions and corrections.
\n\n\n\nWhen faced with potential misconduct, IntechOpen accepts its responsibility to maintain the integrity of the academic record. For particularly complex cases, IntechOpen might ask for the assistance of formal industry bodies or seek advice from an appropriate team of advisors.
\n\nIntechOpen's advisors are professionals and scholars with broad knowledge and understanding of different aspects of the scientific publishing process: editorial, authorship, and reviewing roles; publication ethics, copyright, and general legal issues; as well as bibliographic and technical standards.
\n\nIn order to provide us with unbiased insights, without compromising the privacy of third parties, IntechOpen presents problematic cases to its advisors in an anonymized format.
\n\nIntechOpen publishes books in the English language. If you are interested in the translation of Book Chapters, please check IntechOpen's Translation Policy.
\n\n\n\nIn line with the Principles of Transparency and Best Practice in Scholarly Publishing, you can access a more detailed description of IntechOpen's Advertising Policy.
\n\n\n\nAt IntechOpen we realize that exceptional circumstances can occur, resulting in a request for a refund. We will honor all justified requests in the specific instances outlined in our Refund Policy.
\n\n\n\nAll chapters will be published via IntechOpen's 'Online First' service meaning chapters will be published individually, immediately after review and before the entire book is ready for publication, allowing content to be shared, searched and cited straightaway, thereby generating early stage interest and momentum for your research
\n\nOnline First Chapters are considered published on the day they are posted and are citable from that date.
\n\nChapters will remain listed as Online First until the final versions of the books are published online. Following publication of the full monograph, Chapters will be redirected from the Online First version and will be available only through the final link of the official published page.
\n\nYou are invited to download, use, reproduce, make derivative works of, display, distribute and cite the Online First works. You can find "How to Cite and Reference" by following the link at the end of each online book chapter. Please be aware that it is possible that further editing and changes might be made before the final release of the book.
\n\nIf there are supplemental materials to the chapter, these will be published at the time the final book is published online.
\n\nReaders and Authors can notify us if they find any errors in the works published under Online First. All major errors will be accompanied by a separate correction notice, erratum or corrigendum (Retraction and Correction Policy.)
\n\nIntechOpen books are available online by accessing all published content on a chapter level.
\n\n\n\nIntechOpen publishes different types of publications.
\n\n\n\n\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6630},{group:"region",caption:"Middle and South America",value:2,count:5911},{group:"region",caption:"Africa",value:3,count:2404},{group:"region",caption:"Asia",value:4,count:12562},{group:"region",caption:"Australia and Oceania",value:5,count:1009},{group:"region",caption:"Europe",value:6,count:17573}],offset:12,limit:12,total:132971},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"11561",title:"Zeolite From Wastes - New Perspectives on Innovative Resources and Their Valorization Process",subtitle:null,isOpenForSubmission:!0,hash:"3ed0dfd842de9cd1143212415903e6ad",slug:null,bookSignature:"Dr. Claudia Belviso",coverURL:"https://cdn.intechopen.com/books/images_new/11561.jpg",editedByType:null,editors:[{id:"61457",title:"Dr.",name:"Claudia",surname:"Belviso",slug:"claudia-belviso",fullName:"Claudia Belviso"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11600",title:"Recent Update on Multiple Myeloma\ufeff",subtitle:null,isOpenForSubmission:!0,hash:"c8e2b12df4fc2d313aced448fe08a63e",slug:null,bookSignature:"Dr. Khalid Ahmed Al-Anazi",coverURL:"https://cdn.intechopen.com/books/images_new/11600.jpg",editedByType:null,editors:[{id:"37255",title:"Dr.",name:"Khalid",surname:"Al-Anazi",slug:"khalid-al-anazi",fullName:"Khalid Al-Anazi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11586",title:"Schizophrenia - Recent Advances and Patient-Centered Treatment Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"2ba14221aca01660b2547004d9b5c2d9",slug:null,bookSignature:"Dr. Jane Yip",coverURL:"https://cdn.intechopen.com/books/images_new/11586.jpg",editedByType:null,editors:[{id:"156214",title:"Dr.",name:"Jane",surname:"Yip",slug:"jane-yip",fullName:"Jane Yip"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11519",title:"Vibration Monitoring and Analysis - Recent Advances",subtitle:null,isOpenForSubmission:!0,hash:"f0d2d82a5c1a49020abf39dc8aabd89d",slug:null,bookSignature:"Dr.Ing. Louay Yousuf",coverURL:"https://cdn.intechopen.com/books/images_new/11519.jpg",editedByType:null,editors:[{id:"322417",title:"Dr.Ing.",name:"Louay",surname:"Yousuf",slug:"louay-yousuf",fullName:"Louay Yousuf"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11445",title:"Multi-Agent Technologies and Machine Learning",subtitle:null,isOpenForSubmission:!0,hash:"d980826615baa6e33456e2a79064c5e8",slug:null,bookSignature:"Prof. Igor Sheremet",coverURL:"https://cdn.intechopen.com/books/images_new/11445.jpg",editedByType:null,editors:[{id:"265237",title:"Prof.",name:"Igor",surname:"Sheremet",slug:"igor-sheremet",fullName:"Igor Sheremet"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11470",title:"Graphene - Recent Advances, Future Perspective and Applied Applications",subtitle:null,isOpenForSubmission:!0,hash:"409e022e3baf48795e816576a6ee66e3",slug:null,bookSignature:"Dr. Mujtaba Ikram, Dr. Asghari Maqsood and Dr. Aneeqa Bashir",coverURL:"https://cdn.intechopen.com/books/images_new/11470.jpg",editedByType:null,editors:[{id:"286820",title:"Dr.",name:"Mujtaba",surname:"Ikram",slug:"mujtaba-ikram",fullName:"Mujtaba Ikram"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11484",title:"Thin Film Deposition - Fundamentals, Processes, and Applications",subtitle:null,isOpenForSubmission:!0,hash:"9c10a55203c2f0f7d47c743e6cfa2492",slug:null,bookSignature:"Dr. Dongfang Yang",coverURL:"https://cdn.intechopen.com/books/images_new/11484.jpg",editedByType:null,editors:[{id:"177814",title:"Dr.",name:"Dongfang",surname:"Yang",slug:"dongfang-yang",fullName:"Dongfang Yang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11620",title:"Tomato - From Cultivation to Processing Technology",subtitle:null,isOpenForSubmission:!0,hash:"cdc23b5aad5d52bc0f0327c453ac7a1b",slug:null,bookSignature:"Prof. Pranas Viskelis, Dr. Dalia Urbonavičienė and Dr. Jonas Viskelis",coverURL:"https://cdn.intechopen.com/books/images_new/11620.jpg",editedByType:null,editors:[{id:"83785",title:"Prof.",name:"Pranas",surname:"Viskelis",slug:"pranas-viskelis",fullName:"Pranas Viskelis"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11468",title:"High Entropy Alloys - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"3b4ef3ce01f8f9b113dc28ac847b8c0d",slug:null,bookSignature:"Prof. Yong A Zhang",coverURL:"https://cdn.intechopen.com/books/images_new/11468.jpg",editedByType:null,editors:[{id:"203937",title:"Prof.",name:"Yong",surname:"Zhang",slug:"yong-zhang",fullName:"Yong Zhang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11525",title:"Wood Industry - Past, Present and Future Outlook",subtitle:null,isOpenForSubmission:!0,hash:"ccb74142053c89e0e572ac1c5d717a11",slug:null,bookSignature:"Prof. Guanben Du and Dr. Xiaojian Zhou",coverURL:"https://cdn.intechopen.com/books/images_new/11525.jpg",editedByType:null,editors:[{id:"291315",title:"Prof.",name:"Guanben",surname:"Du",slug:"guanben-du",fullName:"Guanben Du"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11691",title:"Orthognathic Surgery and Dentofacial Deformities",subtitle:null,isOpenForSubmission:!0,hash:"413b0d1441beac767fe0fbf7c0e98622",slug:null,bookSignature:"Dr. H. Brian Sun",coverURL:"https://cdn.intechopen.com/books/images_new/11691.jpg",editedByType:null,editors:[{id:"184302",title:"Dr.",name:"H. Brian",surname:"Sun",slug:"h.-brian-sun",fullName:"H. Brian Sun"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11655",title:"Atrial Fibrillation - Diagnosis and Management in the 21st Century",subtitle:null,isOpenForSubmission:!0,hash:"a0ecc730df6b37a0e1cb00968a5be34d",slug:null,bookSignature:"Prof. Ozgur Karcioglu and Associate Prof. Funda Karbek Akarca",coverURL:"https://cdn.intechopen.com/books/images_new/11655.jpg",editedByType:null,editors:[{id:"221195",title:"Prof.",name:"Ozgur",surname:"Karcioglu",slug:"ozgur-karcioglu",fullName:"Ozgur Karcioglu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:42},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:12},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:24},{group:"topic",caption:"Computer and Information Science",value:9,count:19},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:18},{group:"topic",caption:"Engineering",value:11,count:65},{group:"topic",caption:"Environmental Sciences",value:12,count:9},{group:"topic",caption:"Immunology and Microbiology",value:13,count:11},{group:"topic",caption:"Materials Science",value:14,count:29},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:124},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:9},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:12},{group:"topic",caption:"Psychology",value:21,count:9},{group:"topic",caption:"Robotics",value:22,count:3},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:3}],offset:12,limit:12,total:424},popularBooks:{featuredBooks:[],offset:0,limit:12,total:null},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",publishedDate:"May 18th 2022",numberOfDownloads:3385,editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11001",title:"Density Functional Theory",subtitle:"Recent Advances, New Perspectives and Applications",isOpenForSubmission:!1,hash:"82d53383af78ab41eb982086c02fb2bb",slug:"density-functional-theory-recent-advances-new-perspectives-and-applications",bookSignature:"Daniel Glossman-Mitnik",coverURL:"https://cdn.intechopen.com/books/images_new/11001.jpg",publishedDate:"May 18th 2022",numberOfDownloads:1875,editors:[{id:"198499",title:"Dr.",name:"Daniel",middleName:null,surname:"Glossman-Mitnik",slug:"daniel-glossman-mitnik",fullName:"Daniel Glossman-Mitnik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10356",title:"Natural Medicinal Plants",subtitle:null,isOpenForSubmission:!1,hash:"943e56ccaaf19ff696d25aa638ae37d6",slug:"natural-medicinal-plants",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/10356.jpg",publishedDate:"May 11th 2022",numberOfDownloads:3842,editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11752",title:"Natural Drugs from Plants",subtitle:null,isOpenForSubmission:!1,hash:"a0a83c0822608ef7592bf16a5ed0ada4",slug:"natural-drugs-from-plants",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/11752.jpg",publishedDate:"May 11th 2022",numberOfDownloads:3008,editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10251",title:"Plankton Communities",subtitle:null,isOpenForSubmission:!1,hash:"e11e441ca2d2d5f631b1b4704505cfb6",slug:"plankton-communities",bookSignature:"Leonel Pereira and Ana Marta Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/10251.jpg",publishedDate:"May 18th 2022",numberOfDownloads:1109,editors:[{id:"279788",title:"Dr.",name:"Leonel",middleName:null,surname:"Pereira",slug:"leonel-pereira",fullName:"Leonel Pereira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10830",title:"Animal Feed Science and Nutrition",subtitle:"Production, Health and Environment",isOpenForSubmission:!1,hash:"79944fc8fbbaa329aed6fde388154832",slug:"animal-feed-science-and-nutrition-production-health-and-environment",bookSignature:"Amlan Kumar Patra",coverURL:"https://cdn.intechopen.com/books/images_new/10830.jpg",publishedDate:"May 18th 2022",numberOfDownloads:1010,editors:[{id:"310962",title:"Dr.",name:"Amlan",middleName:"Kumar",surname:"Patra",slug:"amlan-patra",fullName:"Amlan Patra"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",publishedDate:"April 28th 2022",numberOfDownloads:3918,editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9670",title:"Current Trends in Wheat Research",subtitle:null,isOpenForSubmission:!1,hash:"89d795987f1747a76eee532700d2093d",slug:"current-trends-in-wheat-research",bookSignature:"Mahmood-ur-Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9670.jpg",publishedDate:"May 11th 2022",numberOfDownloads:1654,editors:[{id:"185476",title:"Dr.",name:"Mahmood-ur-Rahman",middleName:null,surname:"Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-ur-Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",publishedDate:"March 16th 2022",numberOfDownloads:7686,editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3444,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"10522",title:"Coding Theory",subtitle:"Recent Advances, New Perspectives and Applications",isOpenForSubmission:!1,hash:"6357e1dd7d38adeb519ca7a10dc9e5a0",slug:"coding-theory-recent-advances-new-perspectives-and-applications",bookSignature:"Sudhakar Radhakrishnan and Sudev Naduvath",coverURL:"https://cdn.intechopen.com/books/images_new/10522.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"26327",title:"Dr.",name:"Sudhakar",middleName:null,surname:"Radhakrishnan",slug:"sudhakar-radhakrishnan",fullName:"Sudhakar Radhakrishnan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10821",title:"Automation and Control",subtitle:"Theories and Applications",isOpenForSubmission:!1,hash:"18463c2291ba306c4dcbabd988227eea",slug:"automation-and-control-theories-and-applications",bookSignature:"Elmer P. Dadios",coverURL:"https://cdn.intechopen.com/books/images_new/10821.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"111683",title:"Prof.",name:"Elmer P.",middleName:"P.",surname:"Dadios",slug:"elmer-p.-dadios",fullName:"Elmer P. Dadios"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11348",title:"Mutagenesis and Mitochondrial-Associated Pathologies",subtitle:null,isOpenForSubmission:!1,hash:"001972b3c5b49367314b13025a449232",slug:"mutagenesis-and-mitochondrial-associated-pathologies",bookSignature:"Michael Fasullo and Angel Catala",coverURL:"https://cdn.intechopen.com/books/images_new/11348.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"258231",title:"Dr.",name:"Michael",middleName:"Thomas",surname:"Fasullo",slug:"michael-fasullo",fullName:"Michael Fasullo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11123",title:"Epoxy-Based Composites",subtitle:null,isOpenForSubmission:!1,hash:"c1c5447cf3b9d6c7688276ac30e80de6",slug:"epoxy-based-composites",bookSignature:"Samson Jerold Samuel Chelladurai, Ramesh Arthanari and M.R.Meera",coverURL:"https://cdn.intechopen.com/books/images_new/11123.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"247421",title:"Dr.",name:"Samson Jerold Samuel",middleName:null,surname:"Chelladurai",slug:"samson-jerold-samuel-chelladurai",fullName:"Samson Jerold Samuel Chelladurai"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10632",title:"Theory and Practice of Tunnel Engineering",subtitle:null,isOpenForSubmission:!1,hash:"7ba17749f9d0b6a62d584a3c320a1f49",slug:"theory-and-practice-of-tunnel-engineering",bookSignature:"Hasan Tosun",coverURL:"https://cdn.intechopen.com/books/images_new/10632.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"79083",title:"Prof.",name:"Hasan",middleName:null,surname:"Tosun",slug:"hasan-tosun",fullName:"Hasan Tosun"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10906",title:"Fungal Reproduction and Growth",subtitle:null,isOpenForSubmission:!1,hash:"f84de0280d54f3b52e3e4585cff24ac1",slug:"fungal-reproduction-and-growth",bookSignature:"Sadia Sultan and Gurmeet Kaur Surindar Singh",coverURL:"https://cdn.intechopen.com/books/images_new/10906.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"176737",title:"Dr.",name:"Sadia",middleName:null,surname:"Sultan",slug:"sadia-sultan",fullName:"Sadia Sultan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10914",title:"Effective Elimination of Structural Racism",subtitle:null,isOpenForSubmission:!1,hash:"f6a2562646c0fd664aca8335bc3b3e69",slug:"effective-elimination-of-structural-racism",bookSignature:"Erick Guerrero",coverURL:"https://cdn.intechopen.com/books/images_new/10914.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"294761",title:"Dr.",name:"Erick",middleName:null,surname:"Guerrero",slug:"erick-guerrero",fullName:"Erick Guerrero"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10664",title:"Animal Reproduction",subtitle:null,isOpenForSubmission:!1,hash:"2d66af42fb17d0a6556bb9ef28e273c7",slug:"animal-reproduction",bookSignature:"Yusuf Bozkurt and Mustafa Numan Bucak",coverURL:"https://cdn.intechopen.com/books/images_new/10664.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"90846",title:"Prof.",name:"Yusuf",middleName:null,surname:"Bozkurt",slug:"yusuf-bozkurt",fullName:"Yusuf Bozkurt"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10940",title:"Plant Hormones",subtitle:"Recent Advances, New Perspectives and Applications",isOpenForSubmission:!1,hash:"5aae8a345f8047ed528914ff3491f643",slug:"plant-hormones-recent-advances-new-perspectives-and-applications",bookSignature:"Christophe Hano",coverURL:"https://cdn.intechopen.com/books/images_new/10940.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"313856",title:"Dr.",name:"Christophe",middleName:"F.E.",surname:"Hano",slug:"christophe-hano",fullName:"Christophe Hano"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10207",title:"Sexual Abuse",subtitle:"An Interdisciplinary Approach",isOpenForSubmission:!1,hash:"e1ec1d5a7093490df314d7887e0b3809",slug:"sexual-abuse-an-interdisciplinary-approach",bookSignature:"Ersi Kalfoğlu and Sotirios Kalfoglou",coverURL:"https://cdn.intechopen.com/books/images_new/10207.jpg",editedByType:"Edited by",publishedDate:"May 25th 2022",editors:[{id:"68678",title:"Dr.",name:"Ersi",middleName:null,surname:"Kalfoglou",slug:"ersi-kalfoglou",fullName:"Ersi Kalfoglou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"198",title:"Physical Therapy",slug:"physical-therapy",parent:{id:"16",title:"Medicine",slug:"medicine"},numberOfBooks:3,numberOfSeries:0,numberOfAuthorsAndEditors:58,numberOfWosCitations:27,numberOfCrossrefCitations:28,numberOfDimensionsCitations:44,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"198",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"7543",title:"Physical Therapy Effectiveness",subtitle:null,isOpenForSubmission:!1,hash:"96855ef0bdc30d253f8fd74aa6cfd363",slug:"physical-therapy-effectiveness",bookSignature:"Mario Bernardo-Filho, Danúbiada Cunha de Sá-Caputo and Redha Taiar",coverURL:"https://cdn.intechopen.com/books/images_new/7543.jpg",editedByType:"Edited by",editors:[{id:"157376",title:"Dr.",name:"Mario",middleName:null,surname:"Bernardo-Filho",slug:"mario-bernardo-filho",fullName:"Mario Bernardo-Filho"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6772",title:"Occupational Therapy",subtitle:"Therapeutic and Creative Use of Activity",isOpenForSubmission:!1,hash:"0f6de90c02282919494d6254e473defe",slug:"occupational-therapy-therapeutic-and-creative-use-of-activity",bookSignature:"Meral Huri",coverURL:"https://cdn.intechopen.com/books/images_new/6772.jpg",editedByType:"Edited by",editors:[{id:"171525",title:"Dr.",name:"Meral",middleName:null,surname:"Huri",slug:"meral-huri",fullName:"Meral Huri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5711",title:"Occupational Therapy",subtitle:"Occupation Focused Holistic Practice in Rehabilitation",isOpenForSubmission:!1,hash:"38180e287b6cb09b8002b7ab485de2c2",slug:"occupational-therapy-occupation-focused-holistic-practice-in-rehabilitation",bookSignature:"Meral Huri",coverURL:"https://cdn.intechopen.com/books/images_new/5711.jpg",editedByType:"Edited by",editors:[{id:"171525",title:"Dr.",name:"Meral",middleName:null,surname:"Huri",slug:"meral-huri",fullName:"Meral Huri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:3,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"55163",doi:"10.5772/intechopen.68799",title:"Virtual Reality and Occupational Therapy",slug:"virtual-reality-and-occupational-therapy",totalDownloads:2601,totalCrossrefCites:4,totalDimensionsCites:6,abstract:"Virtual reality is three dimensional, interactive and fun way in rehabilitation. Its first known use in rehabilitation published by Max North named as “Virtual Environments and Psychological Disorders” (1994). Virtual reality uses special programmed computers, visual devices and artificial environments for the clients’ rehabilitation. Throughout technological improvements, virtual reality devices changed from therapeutic gloves to augmented reality environments. Virtual reality was being used in different rehabilitation professions such as occupational therapy, physical therapy, psychology and so on. In spite of common virtual reality approach of different professions, each profession aims different outcomes in rehabilitation. Virtual reality in occupational therapy generally focuses on hand and upper extremity functioning, cognitive rehabilitation, mental disorders, etc. Positive effects of virtual reality were mentioned in different studies, which are higher motivation than non‐simulated environments, active participation of the participants, supporting motor learning, fun environment and risk‐free environment. Additionally, virtual reality was told to be used as assessment. This chapter will focus on usage of virtual reality in occupational therapy, history and recent developments, types of virtual reality technologic equipment, pros and cons, usage for pediatric, adult and geriatric people and recent research and articles.",book:{id:"5711",slug:"occupational-therapy-occupation-focused-holistic-practice-in-rehabilitation",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Occupation Focused Holistic Practice in Rehabilitation"},signatures:"Orkun Tahir Aran, Sedef Şahin, Berkan Torpil, Tarık Demirok and\nHülya Kayıhan",authors:[{id:"172938",title:"Prof.",name:"Hulya",middleName:null,surname:"Kayihan",slug:"hulya-kayihan",fullName:"Hulya Kayihan"},{id:"183079",title:"Ph.D.",name:"Sedef",middleName:null,surname:"Şahin",slug:"sedef-sahin",fullName:"Sedef Şahin"},{id:"196848",title:"M.Sc.",name:"Orkun Tahir",middleName:null,surname:"Aran",slug:"orkun-tahir-aran",fullName:"Orkun Tahir Aran"},{id:"197159",title:"Mr.",name:"Tarık",middleName:null,surname:"Demirok",slug:"tarik-demirok",fullName:"Tarık Demirok"},{id:"197312",title:"M.Sc.",name:"Berkan",middleName:null,surname:"Torpil",slug:"berkan-torpil",fullName:"Berkan Torpil"}]},{id:"61806",doi:"10.5772/intechopen.78312",title:"Executive Functions and Neurology in Children and Adolescents",slug:"executive-functions-and-neurology-in-children-and-adolescents",totalDownloads:1707,totalCrossrefCites:3,totalDimensionsCites:5,abstract:"This chapter discusses the theoretical and methodological issues of creating a developmental perspective on executive function (EF) in childhood and adolescence. Focusing on school periods, this section outlines the development of the basic components of EF—inhibition, working memory, and attention. Cognitive and neurophysiological evaluations show that despite the emergence of EF in the first few years of life, it continues to grow significantly in childhood and adolescence. The components vary slightly according to their developmental sequence. The chapter links findings to long-standing developmental issues (i.e. developmental sequences and processes) and suggests the necessary research to establish a developmental framework covering early childhood throughout adolescence.",book:{id:"6772",slug:"occupational-therapy-therapeutic-and-creative-use-of-activity",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Therapeutic and Creative Use of Activity"},signatures:"Gokcen Akyurek",authors:[{id:"197265",title:"Dr.",name:"Gokcen",middleName:null,surname:"Akyurek",slug:"gokcen-akyurek",fullName:"Gokcen Akyurek"}]},{id:"55024",doi:"10.5772/intechopen.68463",title:"Occupational Therapy in Oncology and Palliative Care",slug:"occupational-therapy-in-oncology-and-palliative-care",totalDownloads:2629,totalCrossrefCites:1,totalDimensionsCites:4,abstract:"Cancer is a chronic disease that may occur in both children and adults. Occupational therapy focuses on the activity limitations and participation problems in their life. Oncology rehabilitation involves in helping an individual with cancer to regain maximum physical, psychological, cognitive, social, and vocational functioning with the limits up to disease and its treatments in an interdisciplinary team concept. These treatment options are associated with the risk of some side effects, including fatigue, pain, cognitive problems, decrease in bone density and muscle endurance, weight loss, and stress- or anxiety-related psychosocial problems. Occupational therapy approaches are a holistic view in a client center and use training in activities of daily living, assistive technology, education of energy conservation techniques, and management of treatment-related problems, such as pain, fatigue, and nausea. In palliative and hospice care, occupational therapists support clients with cancer by minimizing the secondary symptoms related to cancer and its treatments. At the end of life, occupational therapy offers to identify the roles and activities that are meaningful and purposeful to the client with cancer and try to determine the barriers that limit their performance. Clients with cancer who have childhood cancer or adult cancer can face problems about body structure and functions, activity, and participation, which may limit their participation to their daily life.",book:{id:"5711",slug:"occupational-therapy-occupation-focused-holistic-practice-in-rehabilitation",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Occupation Focused Holistic Practice in Rehabilitation"},signatures:"Sedef Şahin, Semin Akel and Meral Zarif",authors:[{id:"183079",title:"Ph.D.",name:"Sedef",middleName:null,surname:"Şahin",slug:"sedef-sahin",fullName:"Sedef Şahin"},{id:"183078",title:"Dr.",name:"Burcu Semin",middleName:null,surname:"Akel",slug:"burcu-semin-akel",fullName:"Burcu Semin Akel"},{id:"198859",title:"Dr.",name:"Meral",middleName:null,surname:"Zarif",slug:"meral-zarif",fullName:"Meral Zarif"}]},{id:"56049",doi:"10.5772/intechopen.69101",title:"Measurement of Participation: The Role Checklist Version 3: Satisfaction and Performance",slug:"measurement-of-participation-the-role-checklist-version-3-satisfaction-and-performance",totalDownloads:2780,totalCrossrefCites:3,totalDimensionsCites:4,abstract:"Participation in society is an area of interest to both clinicians and population researchers. Measurement of participation is therefore important, yet differences in definition, in terms of both content and scope, have made general agreement on one instrument tool elusive. What is recognized is the need for a theoretically based tool that captures both the insider and the outsider perspective. The outsider perspective, inclusive of the generally held views of a society, supports the utility for aggregating population data, whereas the insider perspective provides the internally held views of an individual needed for client-centered treatment planning. The Role Checklist Version 3 modifies one of the most commonly used assessment tools in occupational therapy practice, has good preliminary psychometric properties, and is theoretically consistent with both the ICF and the Model of Human Occupation. The Model of Human Occupation is the most widely used theoretical model in occupational therapy. This chapter provides an overview of the theoretical development, empirical testing, and implications for use of this participation measure by occupational therapists along with implications for population researchers.",book:{id:"5711",slug:"occupational-therapy-occupation-focused-holistic-practice-in-rehabilitation",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Occupation Focused Holistic Practice in Rehabilitation"},signatures:"Patricia J. Scott, Kelsey McKinney, Jeff Perron, Emily Ruff and Jessica\nSmiley",authors:[{id:"195495",title:"Dr.",name:"Patricia J",middleName:null,surname:"Scott",slug:"patricia-j-scott",fullName:"Patricia J Scott"},{id:"208801",title:"Dr.",name:"Kelsey G.",middleName:null,surname:"McKinney",slug:"kelsey-g.-mckinney",fullName:"Kelsey G. McKinney"},{id:"208802",title:"Mr.",name:"Jeffrey M.",middleName:null,surname:"Perron",slug:"jeffrey-m.-perron",fullName:"Jeffrey M. Perron"},{id:"208803",title:"Dr.",name:"Emily G.",middleName:null,surname:"Ruff",slug:"emily-g.-ruff",fullName:"Emily G. Ruff"},{id:"208804",title:"Dr.",name:"Jessica L.",middleName:null,surname:"Smiley",slug:"jessica-l.-smiley",fullName:"Jessica L. Smiley"}]},{id:"69611",doi:"10.5772/intechopen.89596",title:"What to Expect: Medical Quality Outcomes and Achievements of a Multidisciplinary Inpatient Musculoskeletal System Rehabilitation",slug:"what-to-expect-medical-quality-outcomes-and-achievements-of-a-multidisciplinary-inpatient-musculoske",totalDownloads:723,totalCrossrefCites:0,totalDimensionsCites:3,abstract:"The incidence of chronic diseases is rising. Rehabilitation plays a vital role in preventing and minimizing the functional limitations associated with chronic conditions and aging. Routine outcome measures include disease-specific and unspecific general health parameters. This study evaluates indicators for medical quality outcomes from 10,373 patients (61.00 ± 13.65 years, 51.7% women) who have undergone orthopedic rehabilitation for three weeks. Inpatient rehabilitation reduces lifestyle-related risk factors, optimizes organ functioning and improves the well-being in the majority of patients (81.3%; SMD = 0.52 ± 0.38). Improvements of unspecific and indication specific outcome parameters can be observed in a comparable magnitude. However, disease specific and unspecific health factors are not directly related to each other (r = 0.19). Age, gender, ICD-classification and time of rehabilitation have an influence on initial values and on indication-specific medical outcomes but are insignificant with regards to improvements in unspecific medical outcome parameters. Inpatient rehabilitation includes two main pathways of medical practice, which can be clearly distinguished in terms of their therapeutic outcome. There are general health interventions, such as lifestyle modifications, diet and physical exercise, and symptom-specific treatments. So multidisciplinary medical rehabilitation improves general well-being and physical functioning as well as reduces risk factors in the majority of patients.",book:{id:"7543",slug:"physical-therapy-effectiveness",title:"Physical Therapy Effectiveness",fullTitle:"Physical Therapy Effectiveness"},signatures:"Vincent Grote, Alexandra Unger, Henry Puff and Elke Böttcher",authors:[{id:"308501",title:"M.D.",name:"Henry",middleName:null,surname:"Puff",slug:"henry-puff",fullName:"Henry Puff"},{id:"308502",title:"Dr.",name:"Vincent",middleName:null,surname:"Grote",slug:"vincent-grote",fullName:"Vincent Grote"},{id:"309934",title:"Dr.",name:"Elke",middleName:null,surname:"Böttcher",slug:"elke-bottcher",fullName:"Elke Böttcher"},{id:"310535",title:"Dr.",name:"Alexandra",middleName:null,surname:"Unger",slug:"alexandra-unger",fullName:"Alexandra Unger"}]}],mostDownloadedChaptersLast30Days:[{id:"55080",title:"Life Skills in Occupational Therapy",slug:"life-skills-in-occupational-therapy",totalDownloads:5978,totalCrossrefCites:3,totalDimensionsCites:0,abstract:"Occupational therapy is a health profession that uses the purposeful activities to achieve multiple and complex rehabilitation aims. The main goals of the occupational therapy are to support the reintegration of individuals in daily living skills as well as to increase their independence and autonomy. Interventions of occupational therapists have primarily focused on self-care, productivity, and leisure time activities. Since the life skills includes a wide range of abilities that enable a person to perform personal care and more complicated tasks such as traveling, shopping, community participation etc., occupational therapists provide life skills training programs to meet the needs of the clients. This chapter aims to contribute to the current understanding and practices of life skills from an occupational therapy perspective. The chapter starts with a brief discussion of the importance of life skills in occupational therapy. After this introduction, the first part takes a look at the definition of life skills and identifies core components of life skills. The second part describes assessment and interventions of life skills. The third one gives an overview about school life skills programs for children and adolescents. Finally, the last part explains some life skills programs in people with disadvantages.",book:{id:"5711",slug:"occupational-therapy-occupation-focused-holistic-practice-in-rehabilitation",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Occupation Focused Holistic Practice in Rehabilitation"},signatures:"Hatice Abaoğlu, Özge Buket Cesim, Sinem Kars and Zeynep Çelik",authors:[{id:"197551",title:"Dr.",name:"Hatice",middleName:null,surname:"Abaoğlu",slug:"hatice-abaoglu",fullName:"Hatice Abaoğlu"},{id:"205199",title:"Dr.",name:"Sinem",middleName:null,surname:"Kars",slug:"sinem-kars",fullName:"Sinem Kars"},{id:"205200",title:"Dr.",name:"Zeynep",middleName:null,surname:"Celik",slug:"zeynep-celik",fullName:"Zeynep Celik"},{id:"205203",title:"Ms.",name:"Özge Buket",middleName:null,surname:"Cesim",slug:"ozge-buket-cesim",fullName:"Özge Buket Cesim"}]},{id:"62493",title:"Occupational Therapy in Forensic Settings",slug:"occupational-therapy-in-forensic-settings",totalDownloads:2480,totalCrossrefCites:2,totalDimensionsCites:2,abstract:"It is necessary for a person to comply with the expectations of society and the rules of law to which these expectations are secured. Offenders turn back to the community after the penalty was executed by isolating from society and some occupations. An occupational imbalance is seen in the individuals, during this penalty period and afterward, because of limited occupational participation. As an occupational being, this affects their physical, mental and psychological well-being. Imprisonment is an important practice in criminal law to punish criminals. This may be necessary for the protection of society from criminals, but successful integration into a community after exiting the prison is the most important factor in preventing recidivism. Occupational therapy focuses on health and well-being by using meaningful and purposeful occupations. Occupation involves any activity that people perform or participate in, such as giving care to themselves or others, working, learning, playing games, and interacting with others. From this perspective, the role of occupational therapists in forensic settings is to determine the abilities of these individuals to congregate their deprived freedoms and use them to train them for an independent and autonomous life; to provide a professional orientation, career counseling, and self-esteem; to gain some habits for physical, spiritual and moral life and to reinforce.",book:{id:"6772",slug:"occupational-therapy-therapeutic-and-creative-use-of-activity",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Therapeutic and Creative Use of Activity"},signatures:"Esma Ozkan, Sümeyye Belhan, Mahmut Yaran and Meral Zarif",authors:null},{id:"70122",title:"Parkinson’s Disease Rehabilitation: Effectiveness Approaches and New Perspectives",slug:"parkinson-s-disease-rehabilitation-effectiveness-approaches-and-new-perspectives",totalDownloads:1990,totalCrossrefCites:2,totalDimensionsCites:2,abstract:"Parkinson’s disease has been considered one of the most important and common neurodegenerative diseases in the world. Its motor and nonmotor signs determine a huge functional loss, leading the individuals to lose their independence. Although the treatment requires a pharmacological approach, physical therapy has confirmed its importance in this process. Today, neurorehabilitation is indispensable to increase many of the cardinal signs of the disease. Using traditional or technological approaches, physical therapy has reached good results in improving motor and nonmotor functions, as well as the quality of life of Parkinsonians. However, it is important to develop and to fortify the physical therapy approach so that we can provide stronger evidence about our practice.",book:{id:"7543",slug:"physical-therapy-effectiveness",title:"Physical Therapy Effectiveness",fullTitle:"Physical Therapy Effectiveness"},signatures:"Luciana Auxiliadora de Paula Vasconcelos",authors:[{id:"98546",title:"Dr.",name:"Luciana Auxiliadora",middleName:null,surname:"De Paula Vasconcelos",slug:"luciana-auxiliadora-de-paula-vasconcelos",fullName:"Luciana Auxiliadora De Paula Vasconcelos"}]},{id:"62210",title:"Occupational Therapy’s Role in the Treatment of Children with Autism Spectrum Disorders",slug:"occupational-therapy-s-role-in-the-treatment-of-children-with-autism-spectrum-disorders",totalDownloads:2687,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Occupational therapists (OT) offer a wide range of therapies for individuals with ASD on the basis of specific deficits and difficulties. This chapter explores the role that OT plays, and the expertise, in relation to the interdisciplinary team. In addition, it discusses and presents empirical support for several therapeutic approaches commonly used by OTs working with individuals with ASD.",book:{id:"6772",slug:"occupational-therapy-therapeutic-and-creative-use-of-activity",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Therapeutic and Creative Use of Activity"},signatures:"Bryan M. Gee, Amy Nwora and Theodore W. Peterson",authors:null},{id:"55049",title:"Community Participation in People with Disabilities",slug:"community-participation-in-people-with-disabilities",totalDownloads:2386,totalCrossrefCites:2,totalDimensionsCites:2,abstract:"Despite the fact that participation is an important building and a valuable target, the conceptualization, identification and measurement methods vary widely. This chapter tried to gain an insider’s perspective from the obstacles that summarize what meaning participation means, how to characterize it, and what prevents and supports participation. Participation is seen as a right and a responsibility attributed to and attributed to both the person and the community. Participation does not take place in a vacuum; the environment dynamically influences participation. The effects of this conceptual framework are discussed for change at the level of evaluation, research and systems to support the participation of the people with disability.",book:{id:"5711",slug:"occupational-therapy-occupation-focused-holistic-practice-in-rehabilitation",title:"Occupational Therapy",fullTitle:"Occupational Therapy - Occupation Focused Holistic Practice in Rehabilitation"},signatures:"Gokcen Akyurek and Gonca Bumin",authors:[{id:"32431",title:"Prof.",name:"Gonca",middleName:null,surname:"Bumin",slug:"gonca-bumin",fullName:"Gonca Bumin"},{id:"197265",title:"Dr.",name:"Gokcen",middleName:null,surname:"Akyurek",slug:"gokcen-akyurek",fullName:"Gokcen Akyurek"}]}],onlineFirstChaptersFilter:{topicId:"198",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:99,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:288,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:11,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"May 24th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:27,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"14",title:"Cell and Molecular Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",isOpenForSubmission:!0,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"15",title:"Chemical Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",isOpenForSubmission:!0,editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",slug:"sukru-beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",biography:"Dr. Şükrü Beydemir obtained a BSc in Chemistry in 1995 from Yüzüncü Yıl University, MSc in Biochemistry in 1998, and PhD in Biochemistry in 2002 from Atatürk University, Turkey. He performed post-doctoral studies at Max-Planck Institute, Germany, and University of Florence, Italy in addition to making several scientific visits abroad. He currently works as a Full Professor of Biochemistry in the Faculty of Pharmacy, Anadolu University, Turkey. Dr. Beydemir has published over a hundred scientific papers spanning protein biochemistry, enzymology and medicinal chemistry, reviews, book chapters and presented several conferences to scientists worldwide. He has received numerous publication awards from various international scientific councils. He serves in the Editorial Board of several international journals. Dr. Beydemir is also Rector of Bilecik Şeyh Edebali University, Turkey.",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",slug:"deniz-ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",biography:"Dr. Deniz Ekinci obtained a BSc in Chemistry in 2004, MSc in Biochemistry in 2006, and PhD in Biochemistry in 2009 from Atatürk University, Turkey. He studied at Stetson University, USA, in 2007-2008 and at the Max Planck Institute of Molecular Cell Biology and Genetics, Germany, in 2009-2010. Dr. Ekinci currently works as a Full Professor of Biochemistry in the Faculty of Agriculture and is the Head of the Enzyme and Microbial Biotechnology Division, Ondokuz Mayıs University, Turkey. He is a member of the Turkish Biochemical Society, American Chemical Society, and German Genetics society. Dr. Ekinci published around ninety scientific papers, reviews and book chapters, and presented several conferences to scientists. He has received numerous publication awards from several scientific councils. Dr. Ekinci serves as the Editor in Chief of four international books and is involved in the Editorial Board of several international journals.",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null},{id:"17",title:"Metabolism",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",isOpenForSubmission:!0,editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",slug:"yannis-karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",biography:"Yannis Karamanos, born in Greece in 1953, completed his pre-graduate studies at the Université Pierre et Marie Curie, Paris, then his Masters and Doctoral degree at the Université de Lille (1983). He was associate professor at the University of Limoges (1987) before becoming full professor of biochemistry at the Université d’Artois (1996). He worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-β-D-glucosaminidase and peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase). From 2002 he contributes to the understanding of the Blood-brain barrier functioning using proteomics approaches. He has published more than 70 papers. His teaching areas are energy metabolism and regulation, integration and organ specialization and metabolic adaptation.",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null},{id:"18",title:"Proteomics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",isOpenForSubmission:!0,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:50,paginationItems:[{id:"81927",title:"Purinergic System in Immune Response",doi:"10.5772/intechopen.104485",signatures:"Yerly Magnolia Useche Salvador",slug:"purinergic-system-in-immune-response",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"80495",title:"Iron in Cell Metabolism and Disease",doi:"10.5772/intechopen.101908",signatures:"Eeka Prabhakar",slug:"iron-in-cell-metabolism-and-disease",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81799",title:"Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases",doi:"10.5772/intechopen.104978",signatures:"Richa Rai",slug:"cross-talk-of-purinergic-and-immune-signaling-implication-in-inflammatory-and-pathogenic-diseases",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81764",title:"Involvement of the Purinergic System in Cell Death in Models of Retinopathies",doi:"10.5772/intechopen.103935",signatures:"Douglas Penaforte Cruz, Marinna Garcia Repossi and Lucianne Fragel Madeira",slug:"involvement-of-the-purinergic-system-in-cell-death-in-models-of-retinopathies",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}}]},overviewPagePublishedBooks:{paginationCount:27,paginationItems:[{type:"book",id:"7006",title:"Biochemistry and Health Benefits of Fatty Acids",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7006.jpg",slug:"biochemistry-and-health-benefits-of-fatty-acids",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Viduranga Waisundara",hash:"c93a00abd68b5eba67e5e719f67fd20b",volumeInSeries:1,fullTitle:"Biochemistry and Health Benefits of Fatty Acids",editors:[{id:"194281",title:"Dr.",name:"Viduranga Y.",middleName:null,surname:"Waisundara",slug:"viduranga-y.-waisundara",fullName:"Viduranga Y. Waisundara",profilePictureURL:"https://mts.intechopen.com/storage/users/194281/images/system/194281.jpg",biography:"Dr. Viduranga Waisundara obtained her Ph.D. in Food Science and Technology from the Department of Chemistry, National University of Singapore, in 2010. She was a lecturer at Temasek Polytechnic, Singapore from July 2009 to March 2013. She relocated to her motherland of Sri Lanka and spearheaded the Functional Food Product Development Project at the National Institute of Fundamental Studies from April 2013 to October 2016. She was a senior lecturer on a temporary basis at the Department of Food Technology, Faculty of Technology, Rajarata University of Sri Lanka. She is currently Deputy Principal of the Australian College of Business and Technology – Kandy Campus, Sri Lanka. She is also the Global Harmonization Initiative (GHI) Ambassador to Sri Lanka.",institutionString:"Australian College of Business & Technology",institution:null}]},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}]},{type:"book",id:"7978",title:"Vitamin A",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7978.jpg",slug:"vitamin-a",publishedDate:"May 15th 2019",editedByType:"Edited by",bookSignature:"Leila Queiroz Zepka, Veridiana Vera de Rosso and Eduardo Jacob-Lopes",hash:"dad04a658ab9e3d851d23705980a688b",volumeInSeries:3,fullTitle:"Vitamin A",editors:[{id:"261969",title:"Dr.",name:"Leila",middleName:null,surname:"Queiroz Zepka",slug:"leila-queiroz-zepka",fullName:"Leila Queiroz Zepka",profilePictureURL:"https://mts.intechopen.com/storage/users/261969/images/system/261969.png",biography:"Prof. Dr. Leila Queiroz Zepka is currently an associate professor in the Department of Food Technology and Science, Federal University of Santa Maria, Brazil. She has more than fifteen years of teaching and research experience. She has published more than 550 scientific publications/communications, including 15 books, 50 book chapters, 100 original research papers, 380 research communications in national and international conferences, and 12 patents. She is a member of the editorial board of five journals and acts as a reviewer for several national and international journals. Her research interests include microalgal biotechnology with an emphasis on microalgae-based products.",institutionString:"Universidade Federal de Santa Maria",institution:{name:"Universidade Federal de Santa Maria",institutionURL:null,country:{name:"Brazil"}}}]},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",biography:"Dr. Hirobumi Suzuki received his Ph.D. in 1997 from Tokyo Metropolitan University, Japan, where he studied firefly phylogeny and the evolution of mating systems. He is especially interested in the genetic differentiation pattern and speciation process that correlate to the flashing pattern and mating behavior of some fireflies in Japan. He then worked for Olympus Corporation, a Japanese manufacturer of optics and imaging products, where he was involved in the development of luminescence technology and produced a bioluminescence microscope that is currently being used for gene expression analysis in chronobiology, neurobiology, and developmental biology. Dr. Suzuki currently serves as a visiting researcher at Kogakuin University, Japan, and also a vice president of the Japan Firefly Society.",institutionString:"Kogakuin University",institution:null}]}]},openForSubmissionBooks:{},onlineFirstChapters:{},subseriesFiltersForOFChapters:[],publishedBooks:{},subseriesFiltersForPublishedBooks:[],publicationYearFilters:[],authors:{paginationCount:25,paginationItems:[{id:"429683",title:"Dr.",name:"Bilal",middleName:null,surname:"Khalid",slug:"bilal-khalid",fullName:"Bilal Khalid",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/429683/images/system/429683.png",biography:"Dr. Bilal Khalid received a Ph.D. in Industrial Business Administration from KMITL Business School, Bangkok, in 2021, and a master’s in International Business Management from Stamford International University, Bangkok, in 2017. Dr. Khalid\\'s research interests include leadership and negotiations, digital transformations, gamification, eLearning, blockchain, Big Data, and management of information technology. Dr. Bilal Khalid also serves as an academic editor at Education Research International and a reviewer for international journals.",institutionString:"KMITL Business School",institution:{name:"King Mongkut's Institute of Technology Ladkrabang",country:{name:"Thailand"}}},{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:"Université Laval",institution:{name:"Université Laval",country:{name:"Canada"}}},{id:"189147",title:"Dr.",name:"Hailan",middleName:null,surname:"Salamun",slug:"hailan-salamun",fullName:"Hailan Salamun",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/189147/images/19274_n.jpeg",biography:"Hailan Salamun, (Dr.) was born in Selangor, Malaysia and graduated from Tunku Ampuan Jamaah Religious High School at Shah Alam. Obtained a degree from the International Islamic University (UIA), Gombak in the field of Islamic Revealed Knowledge and Heritage. Next, I furthered my studies to the professional level to obtain a Diploma in Education at UIA. After serving for several years in school, I furthered my studies to the Master of Dakwah and Leadership at Universiti Kebangsaan Malaysia (UKM), Bangi. I graduated with a Doctor of Philosophy in Principalship Leadership from the University of Malaya (UM) in 2010. I am currently a senior lecturer in the Department of Nationalism and Civilization, Center for Basic and Continuing Education, Universiti Malaysia Terengganu. Prior to that, I had served in several educational institutions such as schools, the Institute of Teacher Education (IPG), and also the University of Malaya. I am also actively involved in paper presentation, writing and publishing. My research interests are focused on leadership, education, society and Islamic civilization. This area of research requires a detailed understanding of Islamic studies and research studies in leadership. Another research interest that I have explored recently is the politics of the Malay community and also the leadership of the mosque.",institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"442081",title:"Dr.",name:"Audrey",middleName:null,surname:"Addy",slug:"audrey-addy",fullName:"Audrey Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Kwame Nkrumah University of Science and Technology",country:{name:"Ghana"}}},{id:"437993",title:"Mr.",name:"Job",middleName:null,surname:"Jackson",slug:"job-jackson",fullName:"Job Jackson",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Management College of Southern Africa",country:{name:"South Africa"}}},{id:"428495",title:"Prof.",name:"Asyraf",middleName:null,surname:"Ab Rahman",slug:"asyraf-ab-rahman",fullName:"Asyraf Ab Rahman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"429650",title:"Dr.",name:"Jacqueline",middleName:null,surname:"Kareem",slug:"jacqueline-kareem",fullName:"Jacqueline Kareem",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Christ University",country:{name:"India"}}},{id:"421041",title:"Dr.",name:"Sunil",middleName:null,surname:"Kumar Ramdas",slug:"sunil-kumar-ramdas",fullName:"Sunil Kumar Ramdas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Jain University",country:{name:"India"}}},{id:"421833",title:"Mr.",name:"Eugene",middleName:null,surname:"Owusu-Acheampong",slug:"eugene-owusu-acheampong",fullName:"Eugene Owusu-Acheampong",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Ghana",country:{name:"Ghana"}}},{id:"239876",title:"Ph.D.",name:"Luciana",middleName:null,surname:"Mourão",slug:"luciana-mourao",fullName:"Luciana Mourão",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Salgado de Oliveira",country:{name:"Brazil"}}},{id:"421735",title:"Dr.",name:"elizabeth",middleName:null,surname:"addy",slug:"elizabeth-addy",fullName:"elizabeth addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"442083",title:"Dr.",name:"James",middleName:null,surname:"Addy",slug:"james-addy",fullName:"James Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437991",title:"Prof.",name:"Muhammad",middleName:null,surname:"Hoque",slug:"muhammad-hoque",fullName:"Muhammad Hoque",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421006",title:"Dr.",name:"Anna",middleName:null,surname:"Uster",slug:"anna-uster",fullName:"Anna Uster",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470243",title:"Dr.",name:"Md Samim",middleName:null,surname:"Al Azad",slug:"md-samim-al-azad",fullName:"Md Samim Al Azad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470244",title:"Dr.",name:"Slimane",middleName:null,surname:"Ed-dafali",slug:"slimane-ed-dafali",fullName:"Slimane Ed-dafali",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421011",title:"Dr.",name:"Afatakpa",middleName:null,surname:"Fortune",slug:"afatakpa-fortune",fullName:"Afatakpa Fortune",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"446057",title:"Mr.",name:"Okedare",middleName:null,surname:"David Olubukunmi",slug:"okedare-david-olubukunmi",fullName:"Okedare David Olubukunmi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421778",title:"Dr.",name:"Fatimah",middleName:"Saeed",surname:"AlAhmari",slug:"fatimah-alahmari",fullName:"Fatimah AlAhmari",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421024",title:"Prof.",name:"Harold Andrew",middleName:null,surname:"Patrick",slug:"harold-andrew-patrick",fullName:"Harold Andrew Patrick",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421065",title:"Ms.",name:"Euzália",middleName:null,surname:"do Rosário Botelho Tomé",slug:"euzalia-do-rosario-botelho-tome",fullName:"Euzália do Rosário Botelho Tomé",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421053",title:"Associate Prof.",name:"Ken",middleName:null,surname:"Kalala Ndalamba",slug:"ken-kalala-ndalamba",fullName:"Ken Kalala Ndalamba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421826",title:"Dr.",name:"Inusah",middleName:null,surname:"Salifu",slug:"inusah-salifu",fullName:"Inusah Salifu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"420823",title:"Prof.",name:"Gardênia da Silva",middleName:null,surname:"Abbad",slug:"gardenia-da-silva-abbad",fullName:"Gardênia da Silva Abbad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437613",title:"MSc.",name:"Juliana",middleName:null,surname:"Legentil",slug:"juliana-legentil",fullName:"Juliana Legentil",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]}},subseries:{item:{id:"19",type:"subseries",title:"Animal Science",keywords:"Animal Science, Animal Biology, Wildlife Species, Domesticated Animals",scope:"The Animal Science topic welcomes research on captive and wildlife species, including domesticated animals. The research resented can consist of primary studies on various animal biology fields such as genetics, nutrition, behavior, welfare, and animal production, to name a few. Reviews on specialized areas of animal science are also welcome.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/19.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11415,editor:{id:"259298",title:"Dr.",name:"Edward",middleName:null,surname:"Narayan",slug:"edward-narayan",fullName:"Edward Narayan",profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",biography:"Dr. Edward Narayan graduated with Ph.D. degree in Biology from the University of the South Pacific and pioneered non-invasive reproductive and stress endocrinology tools for amphibians - the novel development and validation of non-invasive enzyme immunoassays for the evaluation of reproductive hormonal cycle and stress hormone responses to environmental stressors. \nDr. Narayan leads the Stress Lab (Comparative Physiology and Endocrinology) at the University of Queensland. A dynamic career research platform which is based on the thematic areas of comparative vertebrate physiology, stress endocrinology, reproductive endocrinology, animal health and welfare, and conservation biology. \nEdward has supervised 40 research students and published over 60 peer reviewed research.",institutionString:null,institution:{name:"University of Queensland",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null,series:{id:"13",title:"Veterinary Medicine and Science",doi:"10.5772/intechopen.73681",issn:"2632-0517"},editorialBoard:[{id:"258334",title:"Dr.",name:"Carlos Eduardo",middleName:null,surname:"Fonseca-Alves",slug:"carlos-eduardo-fonseca-alves",fullName:"Carlos Eduardo Fonseca-Alves",profilePictureURL:"https://mts.intechopen.com/storage/users/258334/images/system/258334.jpg",institutionString:null,institution:{name:"Universidade Paulista",institutionURL:null,country:{name:"Brazil"}}},{id:"191123",title:"Dr.",name:"Juan José",middleName:null,surname:"Valdez-Alarcón",slug:"juan-jose-valdez-alarcon",fullName:"Juan José Valdez-Alarcón",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSBfcQAG/Profile_Picture_1631354558068",institutionString:"Universidad Michoacana de San Nicolás de Hidalgo",institution:{name:"Universidad Michoacana de San Nicolás de Hidalgo",institutionURL:null,country:{name:"Mexico"}}},{id:"161556",title:"Dr.",name:"Maria Dos Anjos",middleName:null,surname:"Pires",slug:"maria-dos-anjos-pires",fullName:"Maria Dos Anjos Pires",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bS8q2QAC/Profile_Picture_1633432838418",institutionString:null,institution:{name:"University of Trás-os-Montes and Alto Douro",institutionURL:null,country:{name:"Portugal"}}},{id:"209839",title:"Dr.",name:"Marina",middleName:null,surname:"Spinu",slug:"marina-spinu",fullName:"Marina Spinu",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRLXpQAO/Profile_Picture_1630044895475",institutionString:null,institution:{name:"University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca",institutionURL:null,country:{name:"Romania"}}},{id:"92185",title:"Dr.",name:"Sara",middleName:null,surname:"Savic",slug:"sara-savic",fullName:"Sara Savic",profilePictureURL:"https://mts.intechopen.com/storage/users/92185/images/system/92185.jfif",institutionString:'Scientific Veterinary Institute "Novi Sad"',institution:{name:'Scientific Veterinary Institute "Novi Sad"',institutionURL:null,country:{name:"Serbia"}}}]},onlineFirstChapters:{paginationCount:11,paginationItems:[{id:"81793",title:"Canine parvovirus-2: An Emerging Threat to Young Pets",doi:"10.5772/intechopen.104846",signatures:"Mithilesh Singh, Rajendran Manikandan, Ujjwal Kumar De, Vishal Chander, Babul Rudra Paul, Saravanan Ramakrishnan and Darshini Maramreddy",slug:"canine-parvovirus-2-an-emerging-threat-to-young-pets",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Recent Advances in Canine Medicine",coverURL:"https://cdn.intechopen.com/books/images_new/11580.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"81271",title:"The Diversity of Parvovirus Telomeres",doi:"10.5772/intechopen.102684",signatures:"Marianne Laugel, Emilie Lecomte, Eduard Ayuso, Oumeya Adjali, Mathieu Mével and Magalie Penaud-Budloo",slug:"the-diversity-of-parvovirus-telomeres",totalDownloads:24,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Recent Advances in Canine Medicine",coverURL:"https://cdn.intechopen.com/books/images_new/11580.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"79209",title:"Virtual Physiology: A Tool for the 21st Century",doi:"10.5772/intechopen.99671",signatures:"Carmen Nóbrega, Maria Aires Pereira, Catarina Coelho, Isabel Brás, Ana Cristina Mega, Carla Santos, Fernando Esteves, Rita Cruz, Ana I. Faustino-Rocha, Paula A. Oliveira, João Mesquita and Helena Vala",slug:"virtual-physiology-a-tool-for-the-21st-century",totalDownloads:139,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"78543",title:"Pulmonary Vein: Embryology, Anatomy, Function and Disease",doi:"10.5772/intechopen.100051",signatures:"Chan I-Ping and Hsueh Tung",slug:"pulmonary-vein-embryology-anatomy-function-and-disease",totalDownloads:172,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"78564",title:"Anatomy of the Rhesus Monkey (Macaca mulatta): The Essentials for the Biomedical Researcher",doi:"10.5772/intechopen.99067",signatures:"Christophe Casteleyn and Jaco Bakker",slug:"anatomy-of-the-rhesus-monkey-macaca-mulatta-the-essentials-for-the-biomedical-researcher",totalDownloads:314,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"77999",title:"Bronchus-Associated Lymphoid Tissue (BALT) Histology and Its Role in Various Pathologies",doi:"10.5772/intechopen.99366",signatures:"Tuba Parlak Ak",slug:"bronchus-associated-lymphoid-tissue-balt-histology-and-its-role-in-various-pathologies",totalDownloads:193,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"78242",title:"Genomic Instability and Cyto-Genotoxic Damage in Animal Species",doi:"10.5772/intechopen.99685",signatures:"María Evarista Arellano-García, Olivia Torres-Bugarín, Maritza Roxana García-García, Daniel García-Flores, Yanis Toledano-Magaña, Cinthya Sofia Sanabria-Mora, Sandra Castro-Gamboa and Juan Carlos García-Ramos",slug:"genomic-instability-and-cyto-genotoxic-damage-in-animal-species",totalDownloads:135,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"78503",title:"Biomechanics of the Canine Elbow Joint",doi:"10.5772/intechopen.99569",signatures:"Thomas Rohwedder",slug:"biomechanics-of-the-canine-elbow-joint",totalDownloads:168,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"78018",title:"Application of Noble Metals in the Advances in Animal Disease Diagnostics",doi:"10.5772/intechopen.99162",signatures:"Gabriel Alexis S.P. Tubalinal, Leonard Paulo G. Lucero, Jim Andreus V. Mangahas, Marvin A. Villanueva and Claro N. Mingala",slug:"application-of-noble-metals-in-the-advances-in-animal-disease-diagnostics",totalDownloads:108,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"77455",title:"Marek’s Disease Is a Threat for Large Scale Poultry Production",doi:"10.5772/intechopen.98939",signatures:"Wojciech Kozdruń, Jowita Samanta Niczyporuk and Natalia Styś-Fijoł",slug:"marek-s-disease-is-a-threat-for-large-scale-poultry-production",totalDownloads:249,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}},{id:"74655",title:"Taxon-Specific Pair Bonding in Gibbons (Hylobatidae)",doi:"10.5772/intechopen.95270",signatures:"Thomas Geissmann, Simone Rosenkranz-Weck, Judith J.G.M. Van Der Loo and Mathias Orgeldinger",slug:"taxon-specific-pair-bonding-in-gibbons-hylobatidae",totalDownloads:383,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Veterinary Anatomy and Physiology",coverURL:"https://cdn.intechopen.com/books/images_new/10665.jpg",subseries:{id:"19",title:"Animal Science"}}}]},publishedBooks:{paginationCount:3,paginationItems:[{type:"book",id:"8977",title:"Protein Kinases",subtitle:"Promising Targets for Anticancer Drug Research",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",slug:"protein-kinases-promising-targets-for-anticancer-drug-research",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Rajesh Kumar Singh",hash:"6d200cc031706a565b554fdb1c478901",volumeInSeries:24,fullTitle:"Protein Kinases - Promising Targets for Anticancer Drug Research",editors:[{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9742",title:"Ubiquitin",subtitle:"Proteasome Pathway",coverURL:"https://cdn.intechopen.com/books/images_new/9742.jpg",slug:"ubiquitin-proteasome-pathway",publishedDate:"December 9th 2020",editedByType:"Edited by",bookSignature:"Xianquan Zhan",hash:"af6880d3a5571da1377ac8f6373b9e82",volumeInSeries:18,fullTitle:"Ubiquitin - Proteasome Pathway",editors:[{id:"223233",title:"Prof.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",profilePictureURL:"https://mts.intechopen.com/storage/users/223233/images/system/223233.png",institutionString:"Shandong First Medical University",institution:{name:"Affiliated Hospital of Shandong Academy of Medical Sciences",institutionURL:null,country:{name:"China"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}}]},submityourwork:{pteSeriesList:[],lsSeriesList:[],hsSeriesList:[],sshSeriesList:[],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"May 24th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:4,numberOfPublishedChapters:288,numberOfPublishedBooks:27,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},subseries:[{id:"14",title:"Cell and Molecular Biology",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",annualVolume:11410,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"79367",title:"Dr.",name:"Ana Isabel",middleName:null,surname:"Flores",fullName:"Ana Isabel Flores",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRpIOQA0/Profile_Picture_1632418099564",institutionString:null,institution:{name:"Hospital Universitario 12 De Octubre",institutionURL:null,country:{name:"Spain"}}},{id:"328234",title:"Ph.D.",name:"Christian",middleName:null,surname:"Palavecino",fullName:"Christian Palavecino",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000030DhEhQAK/Profile_Picture_1628835318625",institutionString:null,institution:{name:"Central University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",fullName:"Francisco Javier Martin-Romero",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",institutionString:null,institution:{name:"University of Extremadura",institutionURL:null,country:{name:"Spain"}}}]},{id:"15",title:"Chemical Biology",keywords:"Phenolic Compounds, Essential Oils, Modification of Biomolecules, Glycobiology, Combinatorial Chemistry, Therapeutic peptides, Enzyme Inhibitors",scope:"Chemical biology spans the fields of chemistry and biology involving the application of biological and chemical molecules and techniques. In recent years, the application of chemistry to biological molecules has gained significant interest in medicinal and pharmacological studies. This topic will be devoted to understanding the interplay between biomolecules and chemical compounds, their structure and function, and their potential applications in related fields. Being a part of the biochemistry discipline, the ideas and concepts that have emerged from Chemical Biology have affected other related areas. This topic will closely deal with all emerging trends in this discipline.",annualVolume:11411,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null,editorialBoard:[{id:"241413",title:"Dr.",name:"Azhar",middleName:null,surname:"Rasul",fullName:"Azhar Rasul",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRT1oQAG/Profile_Picture_1635251978933",institutionString:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",fullName:"Sergey Sedykh",profilePictureURL:"https://mts.intechopen.com/storage/users/178316/images/system/178316.jfif",institutionString:null,institution:{name:"Novosibirsk State University",institutionURL:null,country:{name:"Russia"}}}]},{id:"17",title:"Metabolism",keywords:"Biomolecules Metabolism, Energy Metabolism, Metabolic Pathways, Key Metabolic Enzymes, Metabolic Adaptation",scope:"Metabolism is frequently defined in biochemistry textbooks as the overall process that allows living systems to acquire and use the free energy they need for their vital functions or the chemical processes that occur within a living organism to maintain life. Behind these definitions are hidden all the aspects of normal and pathological functioning of all processes that the topic ‘Metabolism’ will cover within the Biochemistry Series. Thus all studies on metabolism will be considered for publication.",annualVolume:11413,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"243049",title:"Dr.",name:"Anca",middleName:null,surname:"Pantea Stoian",fullName:"Anca Pantea Stoian",profilePictureURL:"https://mts.intechopen.com/storage/users/243049/images/system/243049.jpg",institutionString:null,institution:{name:"Carol Davila University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"203824",title:"Dr.",name:"Attilio",middleName:null,surname:"Rigotti",fullName:"Attilio Rigotti",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:null,institution:{name:"Pontifical Catholic University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"300470",title:"Dr.",name:"Yanfei (Jacob)",middleName:null,surname:"Qi",fullName:"Yanfei (Jacob) Qi",profilePictureURL:"https://mts.intechopen.com/storage/users/300470/images/system/300470.jpg",institutionString:null,institution:{name:"Centenary Institute of Cancer Medicine and Cell Biology",institutionURL:null,country:{name:"Australia"}}}]},{id:"18",title:"Proteomics",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",annualVolume:11414,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null,editorialBoard:[{id:"72288",title:"Dr.",name:"Arli Aditya",middleName:null,surname:"Parikesit",fullName:"Arli Aditya Parikesit",profilePictureURL:"https://mts.intechopen.com/storage/users/72288/images/system/72288.jpg",institutionString:null,institution:{name:"Indonesia International Institute for Life Sciences",institutionURL:null,country:{name:"Indonesia"}}},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",fullName:"Cesar Lopez-Camarillo",profilePictureURL:"https://mts.intechopen.com/storage/users/40928/images/3884_n.png",institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",institutionURL:null,country:{name:"Mexico"}}},{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",fullName:"Shymaa Enany",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRqB9QAK/Profile_Picture_1626163237970",institutionString:null,institution:{name:"Suez Canal University",institutionURL:null,country:{name:"Egypt"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/65774",hash:"",query:{},params:{id:"65774"},fullPath:"/chapters/65774",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()